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CHAPTER I 
 
INTRODUCTION 
 
Simian Virus 40 Overview 
Simian Virus 40: The History 
 Simian Vacuolating Virus 40 (SV40) is one of the first two DNA tumor viruses 
discovered.  In the 1950’s there was a severe outbreak of the polio virus.  Scientists Dr. 
Jonas Salk and Albert Sabin had isolated the poliovirus strain and worked to develop 
vaccines.  Dr. Salk determined that if the poliovirus strain was inactivated by formal in, 
it could then be injected into children.  Dr. Sabin would weaken the live poliovirus 
strain by passaging it through various host cells and then orally administered to 
children.  In 1956, Dr. Sabin was passaging the poliovirus through African Green 
Monkey kidney cells.    In 1960, Dr. Benjamin Sweet and Dr. Maurice Hilleman, of 
Merck, discovered that viruses are commonly carried by monkeys and will contaminate 
tissue cell cultures.  SV40 was one of those viruses that was able to contaminate 
monkey kidney cells.
1
  In the same year, Dr. Bernice Eddy, of the NIH, determined that 
SV40 was indeed contaminating the cell cultures used to passage and grow the 
poliovirus in the production the polio vaccine.  Subsequent research isolated SV40 from 
normal monkey kidney cells, the Sabin poliovirus vaccine stocks, and another 
adenovirus vaccine that was utilizing the same type of cells.  Upon analysis of the Salk 
poliovirus vaccine, SV40 was discovered there as well.  During the Salk vaccine 
production, the formalin treatment successfully inactivated the poliovirus but was 
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insufficient to inactivate SV40.   From 1955 to 1963 approximately 100 million people 
in the United States were accidentally exposed to SV40.
2
   
In the monkey, SV40 causes a persistent infection in the kidney without really 
harmful side effects
3
.  Reports that SV40 could produce tumors in hamsters, prompted 
the government to require screening of all the new stocks of the polio vaccine  
4–9
.   
SV40 was also shown to infect human cells, which prompted decades of epidemiogical 
research across the United States and Europe, following patients who had received 
contaminated virus to determine whether they developed cancer at a higher rate
10–13
.  
The results of these studies caused the Centers for Disease Control and Prevention to 
pronounce that there is no evidence that SV40-contaminated vaccine stocks have caused 
cancer in the humans
14
.   However, technological advances have caused researchers to 
revisit the relationship of SV40 and human disease including cancer.   Some scientists 
have discovered traces of SV40 in some human tumors like pleural mesothelioma (a 
form of lung cancer), osteosarcoma, ependymoma and choroid plexus tumors of the 
brain, and recently non-Hodgkin's lymphoma
15–24
.  Still other researchers have presented 
evidence that SV40 has no relationship with cancer formation 
25–30
.  This topic is still 
rigorously researched and has become highly controversial.   
 The decades of SV40 study have revealed important information about the virus. 
SV40 has been classified as a polyomavirus. The name Polyomavirus means a virus 
with the ability to produce multiple tumors.  Polyoma is a genus of viruses that have 
been researched extensively.  This genus used to be a member of the now disbanded 
Papovaviridae family along with the rabbit polyomavirus and papillomavirus.  One type 
of papillomavirus is the Human Papillomavirus (HPV).  In recent years HPV has been 
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identified as a causative agent for more than 90% of human cervical cancer
31
.  Having 
this human cancer inducing cousin fuels the idea that SV40 may have the ability to 
cause cancer as well. 
  Along with SV40, the members of the genus Polyomavirus members include the 
JC virus (JCV) and BK virus (BKV).   SV40 is a rhesus monkey virus, but BKV and 
JCV are human polyomaviruses.   Both viruses exist commonly in the human population 
and will form an infection in 90% of humans early on in their life
32
.  In fact, 
approximately 80% of the United States’ adult population has antibodies to both BKV 
and JCV.  JCV can infect the respiratory system, kidneys, or brain of humans.  In 
patients with compromised immune systems, JCV can cause the fatal progressive 
multifocal leukoencephalopathy, a neurodegenerative disease.  This virus affects about 
5% of all AIDS patients
33
.  Polymerase chain reaction (PCR) data has linked JCV to 
neural cancers
34
.  In humans, BKV produces a mild respiratory infection and can affect 
the kidneys of immunosuppressed transplant patients.   BKV has also been found in 
human tumors
32
.   These three members have approximately 70% sequence identity
35
 
and have similar life cycles.  Therefore, it is understandable that pathogenic and 
possible oncogenic properties of polyomaviruses have led to an increased effort to 
determine their biology and dynamics.   
 
Simian Virus 40:  The Biology  
SV40 is a small, non-enveloped, icosahedral DNA virus that is approximately 45 nm 
in diameter.  Figure 1.1 shows an X-ray diffraction image of the SV40 particle (pdb id: 
1SVA)
36
.  The SV40 virus can infect a cell by binding onto the surface of a cell via the 
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Figure 1.1: X-ray diffraction image of  
 SV40 virus particle. PDB  id: 1SVA 
receptors ganglioside GM1, which is located in 
lipid rafts, and via the major histocompatibility 
complex (MHC) receptor class 1 molecule.  
MHC-1 is expressed by most cell types, which 
suggests that SV40 should be able to bind to 
many cell surfaces and infect various types of 
cells.  Once attached to MHC-1, SV40 is 
enclosed into caveolae, which is then released from the membrane into the cell.
37,38
  The 
virus containing caveolar vesicle associates 
with the caveosomes in the cytoplasm.  
SV40 can remain in the caveosomes for 
several hours before it is moved along 
microtubules to the endoplasmic reticulum 
(ER).  From the ER, SV40 travels through 
nuclear pore complexes into the nucleus 
where it stimulates transcription and 
replication of its genome.
38
 A schematic 
diagram of this process can be seen if 
Figure 1.2. If the virus has infected a 
permissive cell, DNA replication will be allowed resulting in cell lysis.  However, in a 
non-permissive cell, DNA replication is not allowed resulting in an aborted viral 
infection or oncogenesis.   
Figure 1.2: Schematic diagram of SV40 viral 
infection.  An SV40 virus particle enters the 
cell via the MHC-1 receptor, travels through 
the cytoplasm in caveolae to the ER and is then 
localized to the nucleus.  
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The genome of SV40 is a single molecule of double-stranded circular DNA that is 
5243 bp in length and encodes both early and late genes.  The early and late promoters 
are organized in opposite 
orientations on either 
side of the regulatory 
region, the SV40 origin 
of replication (ori) 
(Figure 1.3)
39
.  There are 
seven proteins known to be encoded by the virus.   The early promoter is activated by 
the cellular DNA transcription machinery.  The genes encoded from the early promoter 
(PE) are large T antigen (Tag), small t antigen (tag), and 17K T antigen (17KT).
39
  
These proteins are expressed soon after viral infection.  The molecular weight of Tag is 
90 kDa and for tag is 17 kDa.  These proteins are translated from the early messenger 
RNA that is transcribed before the start of viral DNA replication.  The large T antigen 
protein is localized exclusively in the nucleus.  The small t antigen exists in all 
fractions as a soluble form.  This activity disrupts the normal pattern of cellular gene 
expression.  The antigen proteins are primary participators in inducing host cell 
transcription, viral DNA replication, virion assembly and many other functions
40
.  Viral 
DNA replication occurs along with the activation of the late promoter.  The genes 
encoded from the late promoter (PL) are VP1, VP2 and VP3 which are the structural 
proteins that create the viral capsid.  The agno protein is also expressed late and its role 
may involve assembly and/or disassembly of the viral capsid
40
.  Only VP1, VP2 and 
Figure 1.3.  Genome Organization of SV40 virus. The 
structural proteins of the virus (green) are encoded from the late 
promoter (PL).  The antigen proteins (blue) are encoded from 
the early promoter (PE). Ori means the origin.  Adapted from 
Saenz-Robles et al, 2001. 
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VP3 are found in the mature virus particle.  The expression of these structural proteins 
results in the assembly of new virus particles.   
As a virus native to kidney cells, which are differentiated cells that don’t divide, 
SV40 had to develop methods for overriding the protective mechanism of cell cycle 
growth arrest.  These methods enable the production of proteins that aid in SV40 
genome replication and propagation of viral progeny.   It has been determined that T 
antigen stimulates the majority of these cell seizure activities yielding a cell that has 
deregulated growth cycles.  In fact, T antigen has shown to be necessary and sufficient 
for cellular transformation
39
.   
The study of Tag has led to numerous advances in many fields including gene 
regulation, RNA splicing, nuclear localization, cellular transformation, DNA replication 
and repair, as well as the functions of tumor suppressor proteins.  Study of how T 
antigen takes over a cell has elucidated the essential cellular proteins and processes. 
Hence, SV40 virus and its T antigen have proven to be a highly useful model system.   
  
Simian Virus 40: The Large T antigen 
 The SV40 T antigen, a 708 amino acid protein, has the ability to affect many 
cellular processes.  T antigen is the only viral protein required for SV40 DNA 
replication and cell transformation.  T antigen forms oligomeric structures and 
experiences post-translational modifications.  The widespread impact and multiple 
functions of Tag can be attributed to its multiple domains.    The domains interact with 
one another in a cooperative manner to direct the cellular infection and transformation.  
Each domain binds to proteins in the host cell and modifies their functions.   
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 T antigen is composed of six structural domains: host range domain (HR), helical 
domain, AAA+ (ATPases associated with various cellular activities) domain,  zinc 
binding domain (Zn-D), origin binding domain (OBD), and a J domain (DNAJ) (see 
Figure 1.4)
41,42
.  All of the domains have specific biological functions and participate in 
the coordination of inter and intra-molecular interactions to alter the environment of the 
host cell to permit and perpetuate viral genome replication and cell transformation.   
The HR domain (628-708) 
occupies the C terminal region of 
T antigen.  While termed a 
functional domain, neither its 
exact function nor structural 
make-up is known.  The HR 
domain is not required for T 
antigen mediated cellular 
transformation
43
.  It functions to 
help the Adenovirus replicate in 
cells (i.e. host range helper 
function (hr/hf)).  The helper 
function has been defined as the 
inability of host range mutant 
viruses to replicate in certain 
types of African green monkey kidney cells
44
.  The HR domain has multiple 
posttranslational modifications (four phosphorylation sites and one acetylation site) , 
Figure 1.4. Structural domains of SV40 T antigen. J 
domain (green – 1GH6); origin binding domain (orange 
– 2TBD); helicase domain (cyan – 1N25); host range 
domain (red). Chimera and Microsoft Powerpoint was 
used to create this representation.  
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which suggests that it is highly regulated and therefore must functionally important
45
.  
In a recent study, mutation of the acetylation site did not affect the replicative abilities 
of SV40.  This same study showed that HR mutant viruses showed defective viral 
replication and lower T antigen and VP1 mRNA levels.  The latter could be alleviated 
by co-expression with wild type HR domain.
46
  Further research is needed to fully 
define the role of the HR domain and to identify any protein interactions it has.  
 Connected to the HR domain are the helical (346-414 and 549-627), AAA+ (415-
548) and Zn-D (266-345) domains.  These domains are all part of the viral replicative 
helicase apparatus (251-627). 
The structure of the helicase 
was determined by X-ray 
crystallography in the 
laboratory of Xiaojiang Chen 
using the T antigen construct 
251-627
47
.  The components of 
the helicase domain are 
responsible for the formation 
of a double hexamer at the 
origin of replication (Figure 
1.5)
48,49
, as well as melting and the unwinding of double stranded DNA.  The zinc 
domain has a globular fold that is stabilized by a zinc atom through a  non-classical zinc 
motif.  This domain is believed to be responsible for stabilizing the hexameric structure .  
The AAA+ domain participates in the ATP binding and hydrolysis.  Research has 
Figure 1.5.  Schematic diagram of the double hexamer at 
the SV40 origin of replication. The helicase domain (cyan 
spheres) forms a hexameric complex. The origin binding 
domain (orange) assembles on the DNA (gray lines)  facing 
one another T antigen hexamer. Three dimensional structures 
of the Tag double hexamer assembled at the origin prior to 
DNA replication were obtained by electron microscopy and 
negative staining and again by cryoelectron microscopy (Valle 
et al. 2000; Gomez-Lorenzo et al. 2003). 
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shown that the presence ATP/ADP promotes the formation of the T antigen hexamer.  
During replication, T antigen molecules assemble on the viral DNA origin by a 
sequence specific interaction mediated by the OBD.  This results in the formation of a 
double hexamer via contacts between its functional domains  (Figure 1.5).  This double 
hexamer spans approximately seven turns of the double stranded DNA.  The helicase 
domain then uses a series of expansion and constriction motions to melt the origin.  The 
double hexamer then continues to unwind the DNA.  As the double stranded DNA 
enters the double hexamer, the unwound single-stranded DNA exits and is protected by 
single stranded binding proteins like replication protein A (RPA).  This mechanism is 
believed to be powered by the ATP hydrolysis activity of the AAA+ domain.  The 
helicase domain also interacts with other cellular proteins such as p53 and the 
polymerase α/primase complex.42,47,48 
The OBD (131-250) was the first T antigen domain to be structurally 
characterized
50
.  The structure of OBD was determined by solution NMR using the T 
antigen protein construct containing residues 131-260 (pdb id: 2tbd)
50
.  OBD is a 
compact structure composed of helices and beta sheets  that recognizes and correctly 
positions T antigen on the DNA origin of replication.  In the electron microscopy image 
in Figure 4, the OBDs are the smaller density at the center and the helicase domain is 
the larger density at the ends.   This and other research has provided evidence that OBD 
and some additional residues may mediate formation of the double hexamer
48,51
.  OBD 
is also involved in the regulation of transcription and replication via the interaction of 
two of its loops with the viral origin, single or double stranded DNA and with RPA.  
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Figure 1.6.   X-ray crystal structures of SV40 T antigen J domain 
and Retinoblastoma tumor suppressor protein pocket domains .  
The J domain of T antighen (green) was crystalized in complex with 
the Aand B domains of pRb (purple). PDB id: 1GH6.   
OBD also functions in T antigen mediated cell cycle progression by promoting the G1/S 
transition through interaction with host cell proteins
52
. 
The J domain (1-102) is found at the N terminus.  The X-ray crystal structure of the 
T antigen J domain (Figure 1.6) was determined using the protein construct contain 
residues 7-117 (pdb id: 1gh6)
53
.  This structure was determined in complex with the 
retinoblastoma protein 
pocket domain (378-
577/645-772).  A J 
domain is a conserved 
motif throughout a class 
of proteins called 
molecular chaperones.  
In T antigen, the J 
domain is attached to the other domains via a thirty residue unstructured region.  A 
cryo-EM study of intact T antigen suggested that the J domain is flexibly tethered to the 
rest of T antigen because density for only the helicase and OBD domains could be 
observed
54
.  A J domain structure has specific features: four compact, anti-parallel 
coiled-coil helices; an absolutely conserved histidine, proline, aspartic acid  tripeptide 
(HPD motif) between helix II and III; helix II region that contains basic residues; 
hydrophobic residues in helices II and III that help stabilize the helix packing
55
.   
The J domains are also functionally conserved.  Various studies have shown that the 
J domain on one molecular chaperone can be swapped for that of another and still 
function
56
.   The T antigen J domain was swapped with the J domains from E-coli DNAJ 
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and yeast Ydj1 and yielded functioning chimeric proteins
57
.  Further evidence shows 
that the J domain of human molecular chaperones Hsj1 and DNAJ2 can be substituted 
for the J domain of T antigen and still function in DNA replication
58
.  The J domain of 
molecular chaperones must be able to bind a co-chaperone of the DNAK protein family 
through the conserved HPD motif.  T antigen binds to heat shock cognate protein 70 
(Hsc70), a mammalian DNAK protein.  As with other molecular chaperones, mutation 
of the T antigen HPD motif abolished the interaction with Hsc70 and its ability to 
function.  A J domain molecular chaperone must stimulate the ATPase activity of their 
DNAK partner and promote the ATP dependent release of a substrate.  A fragment of T 
antigen (1-136) was able to perform both of these activities
59
.  The structural, functional 
and biochemical characteristics show that the J domain of T antigen is functional and 
that T antigen can operate as a molecular chaperone.  The J domain of T antigen has 
been shown to be required for multiple cellular processes including DNA replication , 
cellular transformation, and tumorigenesis
59
.  This suggests that the chaperone activity 
of T antigen may be a key mechanism by which these processes occur.   
 In addition to the structural and functional domains of T antigen, there is a 
binding motif that is crucial for the ability of T antigen to transform a cell.  This motif 
is called the LXCXE.  This motif is proximal to the J domain and extends from residue 
103 to 107 and is required for stable association with many proteins in the pRb protein 
family.  T antigen is able to bind and inactivate pRb proteins.  The J domain is required 
for this activity and it appears that the chaperone function is critical for pRb 
inactivation. 
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SV40 T antigen and molecular chaperones 
 Molecular chaperones are expressed in times of cellular stress, like viral 
infection.  The heat shock classes of molecular chaperones were the first to be 
discovered.  Once expressed, their most common function is to assist with proper 
protein folding.  However, their functions have expanded to include preventing protein 
aggregation, stabilizing unfolded proteins, clathrin uncoating, unfolding proteins for 
membrane translocation or degradation and others.  For example, the chaperonins 
(Hsp60) are mitochondrial proteins that tend to be responsible for the transportation and 
refolding of proteins from the cytoplasm into the mitochondrial matrix.   The Hsp90 
chaperones are the most abundant type in the cytosol and are involved in intracellular 
transport, maintenance, degradation, cell signaling and tumor repression
60
.  The focus of 
this work is on a member of the Hsp40/Hsc70 chaperone family and its interactions.   
 The Hsc70 chaperones have a conserved structure which includes an ATPase 
domain.  Hsc70 can hydrolyze ATP resulting in a conformational change and some 
effect on a bound substrate.  This mechanism allows Hsc70 to prevent protein 
aggregation, refold denatured proteins, transport proteins through membranes, and 
disrupt multi-protein complexes.  However, the intrinsic ATPase activity of Hsc70 is 
weak.  Boosting the ATPase activity is the responsibility of the co -chaperones/Hsp40/J 
proteins.    
 Proteins that contain J domains are highly conserved in nature.  All members of 
the 40 kDa heat shock proteins (Hsp40) family of molecular chaperones contain a J 
domain.  There are three types of J proteins.  Type I proteins contain a J domain, a 
glycine-phenyalanine rich (G/F) region and a zinc finger-like domain.  Type II proteins 
13 
 
have a J domain and the G/F region.  The C terminal regions of the Type I and Type II 
Hs40 proteins have some weak homology.  Type III proteins only have a J domain.
56,61,62
   
Figure 1.7 shows a few examples of each type of Hsp40 chaperone
62
.   There are many J 
proteins with many different functions.   Even though their functions vary, they all have 
the ability to recruit and regulate the activity of the Hsc70
55
.  Aside from stimulating 
ATPase activity of Hsc70, J proteins can also promote substrate interaction, alter the 
phosphorylation state, and induce degradation of protein substrates.   
 T antigen is classified as a Type III, Hsp40 molecular chaperone.  Research has 
shown that Hsc70 will bind to T antigen via the universally conserved HPD tripeptide 
Figure 1.7. Classification of Hsp40/J proteins.  Type I proteins are the canonical Hsp40s 
which contain a J domain (green), Gly-Phe (G/F) rich region (gold), and a zinc finger-like 
region (red).  Examples of Type I proteins are DNAJ and Ydj1p, the E -coli and yeast 
Hsp40 homologs, respectively. Type II proteins contain only the J domain and the G/F 
region. Examples of Type II are HdjJ1, the human Hsp40 homolog and CbpaA, an E-coli 
analogue of DNAJ that recognizes curved DNA.  Type III, contain only a J domain at 
varying places in the structure. Examples of Type II include, SV40 T antigen, Hsj1 
(neuronal function), zuotin (Z-DNA binding), Sec63p (protein translocation), auxi lin 
(clathrin uncoating), P58
IPK
 (PKR-kinase inhibitor).  Adapted from Kelly 1998. 
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in the J domain.  The ATPase activity of Hsc70 is stimulated by specifically increasing 
the rate of ATP hydrolysis
56
.  It has been noted that maximal ATPase activity occurs 
when Hsp40 and a substrate are present
63
.  In the absence of a protein substrate, the 
Hsc70/Hsp40 interaction is dynamic and of low affinity.  It has been proposed that the 
Hsp40 is pre-bound with a substrate that it then presents to Hsc70.  The energy of the 
ATPase cycle allows Hsc70 to fold, unfold, disassemble protein complex or perform 
some other function on the substrate.  After the work of Hsc70 is complete, Hsp40 
disassociates.
56
       
This interaction of T antigen and Hsc70 is essential for  cellular transformation.  
During this process, T antigen binds and modifies the functions of various proteins.   
The interaction of T antigen with pRb family of tumor suppressor proteins is also 
essential for cellular transformation.  However, instead of assisting pRb in a beneficial 
manner, T antigen inactivates these proteins.  It is probable that T antigen utilizes its 
ATP hydrolysis-driven chaperone activity to inactivate pRb protein.  Inactivation of this 
protein supports the self-propagation and cellular domination of the SV40 virus.   
 
Retinoblastoma Protein Family 
 The retinoblastoma proteins (Rb) are tumor suppressors that belong to the so-
called “pocket protein” family.  The members of this family (pRb, p107 and p130) 
contain a conserved binding region called a pocket through which they bind cellular and 
viral proteins.  The structure contains a small pocket and large pocket (Figure 1.8A). 
The foundation of the small pocket domain is the two cyclin-folds, A and B, which are 
separated by a spacer region.  This spacer region is different in each family member.  
15 
 
The large pocket contains the small pocket plus the C terminal region.
64
  The term 
pocket implies that the A and B domains form a conserved receptacle or cavity-like 
structure in which the binding of all proteins would occur.  However, various studies 
have shown that Rb binding proteins associate with one or both of the A and B domains 
along with other regions of Rb
64
.  Therefore, the term pocket is not an accurate 
description of its structure or mechanism of binding but simply the common term used 
in the field for the Rb proteins. 
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Rb proteins are key regulators at various stages of cell development. Together, 
these proteins have been implicated in many cellular processes, such as regulation of 
Figure 1.8. Rb domain structure, binding and function in multiple cellular processes.  
A. The domain organization of Rb highlighting the  small and large pocket domains as well 
as the spacer.  The Adenovirus oncoprotein E1A, Human Papillomavirus oncoprotein E7, 
and Simian Virus 40 Tag binds to Rb in the region of the A and B domains resulting in 
inactivation of the protein.  The E2F transcription factor binds within the larger pocke t 
domain. Adapted from Dick 2007 and Helt et al. 2003. B. Rb proteins are involved in many 
cellular processes along various points in the cell cycle.  Adapted from Classon et al 2002 
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the cell cycle, DNA-damage responses, DNA repair, DNA replication, protection 
against apoptosis, and differentiation, all of which could contribute to its funct ion as a 
tumor suppressor (Fig 1.8)
65,66
.  The pRb protein is the most frequently mutated or 
inactivated in human cancer.
61
  Due to its many roles, it is highly probable that one of 
the proteins on the pRb path is disrupted in all cancers.  
The gene for pRb was the first tumor suppressor gene to be cloned.   Since that 
time great effort has been placed on determining its structure and biochemical function. 
The pRb protein, which has 928 amino acids, consists of three parts: a structured N 
terminal region, the above noted pocket domain and a predominately disordered C 
terminus.
67,68
  The pocket domain is the minimum requirement for pRb binding to 
proteins containing an LXCXE motif.  Two crystal structures of pRb pocket domain 
have been determined.  One structure is in complex with an LXCXE peptide from the 
HPV E7 protein
69
 and the other bound to an LXCXE and J domain containing SV40 T 
antigen fragment
68
 (Figure 1.6).  Both structures show that pRb is mostly helical. These 
structures also revealed a well-conserved region on pRb that is the binding cleft for the 
LXCXE motif. 
The primary function of pRb is as a repressor of transcription-associated proteins 
required for the G1/S phase transition.   This repression results in cell cycle growth 
arrest.  The pRb protein interacts with members of the E2F class of transcription 
factors.  There are nine members of the mammalian E2F family: E2F1-2, 3a-b, and 4-8.  
This family is divided into two functional groups: transcriptional activators (E2F1-3a) 
and repressors (E2F3b-8).
70,71
  The activator E2Fs stimulate cell cycle progression and 
the repressor E2Fs are thought to be involved in cell cycle exit and cell 
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differentiation
70
.  Both of these groups contain similar domains including a DNA 
binding domain and the DP1-2 heterodimerization domain (except E2F7-8).  This 
heterodimerization domain allows the E2F proteins to form a complex with their 
dimerization partner 1 or 2 (DP1, DP2).  Binding with DP1 or DP2 provides an 
additional DNA binding site, increasing E2F binding stability and functional ability as a 
transcriptional regulator of genes involved in S-phase entry, DNA replication, 
checkpoint control, repair, mitosis, differentiation and apoptosis
70,72
.   
Most E2F members (E2F1-5) contain an Rb binding domain as well.  The 
transcriptional activation domain of E2F1-3a and sometimes E2F4 interacts with the 
pRb protein
70,73
.  Under normal circumstances, hypo-phosphorylated pRb protein binds 
E2F-DP during early G1 phase and inhibits cell cycle progression.  In late G1, hyper-
phosphorylation of pRb, by both Cdk4/6-cyclin D and Cdk2-cyclin E, releases and thus 
activates the E2F/DP complex.
67
  Disruption of this highly regulated system, yields 
unrestrained cell growth.  When a cell is infected by the SV40 virus, T antigen can form 
a stable complex with pRb and inactivate it.  Inactivation of pRb results in the release 
of E2F-DP to synthesize DNA, and causes aneuploidy and the promotion of tumor 
development
74
.  The T antigen mediated inactivation of pRb is necessary for cellular 
transformation.  As previously mentioned, the J domain and the T antigen co -chaperone 
are also necessary for cell transformation.  The interaction among the proteins required 
suggests that T antigen mediated transformation is driven by its chaperone activity.  
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The Chaperone Model 
T antigen binds pRb proteins via a conserved LXCXE motif located on its linker 
between the J domain and OBD.   Upon binding, T antigen can facilitate the release of 
E2F-DP, which results in aberrant cellular proliferation.  This mechanism is dependent 
upon Hsp70, ATP hydrolysis, and the J domain
61
.    
A mechanistic model has been proposed whereby T antigen binds the Rb/E2F-
DP1 complex, and when the J domain recruits Hsp70 and induces ATP hydrolysis , and 
the energy is used to liberate E2F-DP (Fig 1.9)
61
.   This model suggests that T antigen 
can alter unique protein complexes, in particular, T antigen either induces disruption of 
or directly causes a conformational change in the pRb-E2F/DP complex.  This suggests 
that the T antigen-Hsp70 complex must be correctly positioned for action on target 
proteins.  The dynamics governing the coordination of this multi-protein interaction are 
unknown.  Does pRb bind in a manner that allows the J domain to move freely in 
solution?  Does pRb binding completely restrict motion of the J domain? There is a  
linker attaching the J domain to the rest of T antigen.  Does it confer flexibility upon 
the J domain allowing it to have a wide range of motion?  Does the binding of pRb 
involve the intervening linker and the OBD resulting in a compact complex?   My thesis 
research was designed to investigate these questions and gain insight into the dynamics 
of the J domain upon binding of the pRb pocket protein. 
Figure 1.9. Chaperone model for Rb inactivation. SV40 Tag binds to the Rb-E2F complex, recruits Hsc70, 
and using the energy of ATP hydrolysis, releases  E2F from  interaction with the Rb protein. 
 
20 
 
Experimental Methods 
Nuclear Magnetic Resonance spectroscopy 
            Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful technique by 
which high resolution information can be obtained on the structure, dynamics and 
interactions of one or more molecules in solution
75–80
.  This technique exploits the NMR 
phenomenon, which arises when certain atoms are placed in a static magnetic field and 
exposed to a second oscillating field.  The NMR-active nuclei will absorb and re-
transmit the electromagnetic radiation at a specific resonance frequency.  Different 
nuclei in a molecule will have different frequencies based upon their local chemical 
environment.  This frequency is proportional to the strength of the magnetic field, and 
when measured relative to a standard frequency it is termed the chemical shift.  
Chemical shifts are indicators of the composition and structure of the molecule.   
 The basic principles of NMR allow this spectroscopic technique to be utilized 
across several areas of science.  NMR spectroscopy is used by chemists to study small 
organic molecules using one and two-dimensional techniques and by biochemists to 
study large complex molecules like proteins using multi-dimensional and multi-nuclear 
techniques.  NMR studies of proteins are performed on samples enriched with one or 
more of the following NMR-active isotopes: 
2
H, 
15
N, 
13
C.  These samples are prepared 
by expressing the protein in a bacterial host with minimal media containing the desired 
isotopes.  It is important that the protein samples are pure and contain a protein 
concentration of at least 50 μM for two-dimensional experiments and at least 250 μM 
for three-dimensional experiments. 
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 The most frequently used NMR experiment for the structural study of proteins is 
the two dimensional 
15
N-
1
H Heteronuclear Single Quantum Coherence (HSQC) 
spectrum.  In this experiment, the sample contains a 
15
N-enriched protein and the 
1
H 
and
 15
N resonance frequencies of each backbone amide are correlated yielding a two-
dimensional spectrum.  The resonances in the spectrum correspond to each 
15
N-
1
H pair, 
so signals are observed from all amino acids except prolines.  The distribution of 
signals in the HSQC spectrum creates a pattern (sometimes termed fingerprint) that is 
unique to each protein.  The number of peaks in the spectrum should correspond , 
approximately, to the number of amino acids in the protein (minus prolines plus side 
Figure 1.10.  Schematic diagram of a two dimensional HSQC. By enriching a protein with the 15N-
isotope we can perform a 2D NMR experiment that correlates a proton (
1
H) with its covalently bound 
nitrogen (
15
N).    A 2D HSQC experiment of the T antigen construct N260 is shown here.  There is a NH 
group for every amino acid (except proline) and every NH group will produce a chemical shift or peak.  
Typically, NH groups from tryptophan residues appear around  10 ppm (black), asparagine and 
glutamine side chains around 7 ppm (black oval); and glycines around 8 ppm (green oval).  An overview 
of the tertiary structure of the protein can be obtained:  an unfolded protein (blue) will have little proton 
dispersion whereas the peaks of a folded protein will be spread widely across the spectrum (red).   
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chains with nitrogen bound protons).  If the protein is unfolded, the peaks will be 
gathered at the center of the 
1
H dimension of the spectrum.  If the protein is folded, the 
peaks are usually well dispersed across the 
1
H dimension of the spectrum and 
distinguishable from one another.  The spectral regions for folded and unfolded proteins 
as well as typical locations for tryptophans, glycines and side chains can be seen in 
Figure 1.10.  This basic 
15
N-
1
H HSQC experiment is highly effective for studying 
proteins and protein complexes with molecular masses up to 40 kDa.  Larger proteins 
require the addition of Transverse Relaxation Optimized Spectroscopy (TROSY) 
techniques to the basic 2D HSQC experiment, to enhance the ability to observe signals. 
For these larger proteins and for protein complexes there are more amino acids 
thus more resonances, which results in spectral overlap.  Also, the larger mass of these 
systems causes slower tumbling of the molecules in solution, faster relaxation rates, 
broader peaks and poor signal to noise ratios.  The 
15
N-
1
H resonances of each peak 
sample are composed of four components that will relax at different rates.  Use of the 
TROSY–HSQC experiment filters out the fastest relaxing component and selectively 
detects only the most slowly relaxing component. In the TROSY-HSQC spectrum, the 
resonances will be narrow and the number of observed signals will  be significantly 
greater than for a standard HSQC spectrum of a large protein.  The TROSY experiment 
is dependent on magnetic field strength.  A magnetic field strength greater than 700 
MHz is optimal
81,82
.  The TROSY-HSQC spectra collected in these studies used an 800 
MHz spectrometer.  
 The unique spectral pattern in the HSQC experiment is a powerful tracking 
device for monitoring changes to the local electronic environment of the protein.  
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Changes in the chemical shift or intensity of the peaks can be induced by upon a 
variation in buffer, pH, temperature, and the introduction of a binding partner.  The 
chemical shift perturbation assay exploits this aspect of the HSQC experiment.  In this 
assay, an unlabeled partner is titrated into the 
15
N-enriched protein sample.  If an 
interaction has occurred, perturbations of the peaks (position shift, broadening, or 
disappearance) will be visible in the spectrum.  The kinetics of the interaction 
determines the type of perturbation that occurs during the titration.  Shifting of peak 
position arises from fast dissociation of the binding complex, or fast exchange.   Fast 
exchange is often observed for weaker binding interactions.  The broadening of peaks is 
a result of intermediate exchange.  In slow exchange, peaks will disappear from the 
spectrum and re-appear at a different position.  The primary benefit of this assay is that 
the protein interaction interface can be identified.    
 For detailed interpretation of the chemical shift perturbation assay, it is essential 
that the resonance assignments be determined.  Resonance assignments can be obtained 
using a variety of strategies and these have been reviewed extensively
75
.  In these 
studies, the backbone resonances of the J domain of SV40 Tag were assigned using 
two- and three-dimensional NMR experiments on 
13
C, 
15
N enriched protein.  The NMR 
experiments collected were: 2D 
15
N-
1
H HSQC and 
13
C-HSQC, as well as 3D HNCACB, 
CBCA(CO)NH, HN(CO)CA, HNCA, HNCO, 
13
C-NOESY, 3D 
15
N-NOESY, and 
15
N-
TOCSY.  Once the resonances have been assigned, the amino acids that are perturbed 
upon a binding interaction can be identified and mapped onto the structural surface of 
the protein.  Utilized in this manner, NMR spectroscopy allows a highly efficient and 
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direct approach to study the structural and functional significance of protein-protein 
interactions. 
Small Angle X-Ray Scattering (SAXS) 
 SAXS belongs to a family of scattering techniques used to characterize 
biological materials such as proteins, and nucleic acids.  The initial principles of SAXS 
were developed in the 1930s by Guinier and Fournet, who showed that this technique 
provided information on the size, shape and internal structure of ordered and disordered 
systems.  Technological and scientific advances have enhanced the importance and 
advantages of SAXS and increased its popularity.  Unlike X-ray crystallography, SAXS 
is done is solution and does not require a crystal line sample.  SAXS also does not have 
molecular mass limitations like that of NMR spectroscopy and can be routinely 
performed on protein samples ranging from ~10 kDa to 300 kDa in size
83
.  However, 
due to the spatial averaging of the random orientation of the molecules in solution, 
SAXS does not provide high resolution information although it can provide structural 
Figure 1.11.  Schematic diagram of SAXS. A monochromatic beam of X-rays is shot at a protein 
sample.  Some of the X-rays from the sample scatter, but most simply pass through the sample 
without any interaction with the protein.  The scattered X-rays yield a scattering pattern that is 
detected by a 2-dimensional flat X-ray detector, typically.  The detector is positioned 
perpendicular to the direction of the X-ray beam. The resultant scattering pattern contains 
information on the structure of the protein. Adapted from Putnam et al. 2007 . 
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insight for challenging systems.  SAXS is especially valuable as a complement to 
structural techniques like Electron Microscopy, X-ray crystallography and NMR 
spectroscopy.  As such, SAXS has proven highly significant to the generation of 
descriptions for the structural assembly and large-scale dynamics of macromolecules 
and their complexes
84,85
.   
The SAXS experiment involves the elastic scattering of X-rays by a solution 
containing 2-10 mg/mL of protein or complex, which are recorded at very low angles 
(typically 0.1 - 10°).  The scattered radiation is registered by a detector producing a 
unique two-dimensional scattering pattern (Figure 1.11). The random positions and 
orientations of the molecules, due to tumbling in solution, yield an intensity that is 
isotropic and proportional to the scattering from a single molecule averaged over all 
orientations
83
.  From the total scattering intensity of the solution, the intensities 
contributed by the buffer are subtracted leaving only the intensities of the protein.   The 
scattering intensities in the 
solution are dominated by the 
abundant solvent so 
appropriate concentrations 
are necessary to obtain good 
intensity from the protein.  
Also, it is imperative that 
protein samples for SAXS 
experiments be pure and 
monodisperse.  Separation of 
Figure 1.12. Scattering curve from N260 bound to pRbA/B.  
This plot is of data that has been integrated and normalized .  
On the y-axis is intensity and the scattering angle is on the x-
axis. 
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Figure 1.13.  Schematic diagram of a Guinier plot.  A non-linear log vs q
2
 indicates 
the presence of protein aggregation in the sample.  Adapted from Putnam et al. 2007 . 
the scattering intensities contributed by the impurities, aggregates, or polydispersity 
creates a significant challenge for SAXS analysis .   
To obtain the scattering profile, scattering intensities of only the protein are 
spherically averaged across all molecular orientations and the intensities, I(q), are 
plotted as a function of the scattering angle, q.   This one-dimensional scattering curve 
represents the protein in reciprocal space (Figure 1.12).  Analysis of low-q region, the 
area closest to the beam stop (also known as the Guinier region), is important for 
determining whether any radiation damage or aggregation has occurred.  The high -q 
region is further from the beam stop and can reveal information about the shape of the 
protein.
84
   
 Initial analysis of the SAXS scattering curve involves Guinier analysis, which 
refers to the assessment of the scattering curve at very small scattering angles, and 
should be performed in the region where the product q x Rg ≤ 1.3.  The plotted data 
should fit to a straight line.  If the residuals for the fit show curvature (i.e. ‘smiling’), 
that is evidence of aggregation in the protein sample (Figure 1.13).  Guinier analysis 
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also allows estimating the radius of gyration (Rg) of the protein directly from the 
scattering data.  Rg represents the mass distribution of the molecule around its center of 
gravity
84
.  The Guinier derived Rg is also known as the reciprocal space Rg.  
Comparison of the Rg values for a protein alone and with a binding partner, can provide 
insight on whether the interaction induced a conformational change.  
 Qualitative assessment of the internal flexibility, structural disorder and 
conformational changes of proteins/complexes in solution can be obtained by applying 
the Kratky analysis 
to the scattering 
curve
85
.  Kratky 
analysis is the plot of 
q
2
*I(q) as a function 
of q.  For 
unstructured 
molecules, the 
Kratky curve sharply 
increases and then 
reaches a plateau in 
the high q regions.  For highly structured, well folded molecules, the curve is parabolic 
and converges toward the baseline in the high q region
84
.  Molecules with a combination 
of structured and unstructured portions will have a Kratky curve with a parabolic peak 
in the low q that turns upward well above the baseline in the high q region (Figure 
1.14)
84,86
. 
Figure 1.14.  Schematic diagram of a Kratky plot.  This plot uses the 
merged data to assess the folded nature of the protein. A globular 
protein will have a distinct peak in the low q region. A protein of 
random coil has no peak but a curve that will plateau.  A protein  with 
both globular and random coil characteristics will have a plot 
representing this.  Adapted from Putnam et al. 2007 . 
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 Fourier transformation 
of the scattering curve into 
real space yields the pair-
distance distribution 
function, P(r).  The P(r) 
function represents the 
frequency of paired distances 
between all the electrons in a 
protein structure
84,87
.  The 
P(r) value is plotted against real space, r (Å) and yields a bell shaped curve that is 
sensitive to the shape of the protein and to any changes that may occur upon an 
interaction.  The curve for an unstructured protein would be narrower then broad for a 
structured compact protein.  A molecule containing unstructured regions and multiple 
structured domains, will have a curve containing various features, like shoulders, 
secondary peaks and an elongated tail that would reflect the shape or domain 
organization of the protein (Figure 1.15)
84,88
.  From the P(r) plot, the maximum 
dimension (Dmax) of the protein can be determined.  The Dmax is the r value at which 
the curve for the P(r) function returns to zero.  An Rg can also be determined from this 
data transformation by integrating the P(r) function with r
2
 over all values of r.  Unlike 
the Rg obtained from the Guinier analysis, this value utilizes all the data and is 
calculated in real space.  The Rg values from both methods should be comparable, if not 
that could indicate aggregation in the sample
84
.  If the structure of the protein of interest 
is available, theoretical Rg and Dmax values can be calculated from the coordinates and 
used for direct comparison with the values derived from the SAXS data.  Overall, the P(r) 
Figure 1.15. Correlation of the P(r) function with various 
molecular shapes. Adapted from Putnam et al. 2007  
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function provides important information on the structure of the molecule and may be useful 
for investigating conformational changes that arise by varying conditions.   
The Porod–Debye law can be applied to the scattering data to more accurately 
assess the presence of flexibility in proteins and protein complexes
89
.  The Porod-Debye 
region represents the scattering intensity decay by capturing the pertinent information 
for identifying folded and flexible proteins.  The Porod-Debye law describes a fourth 
power approximation to the relationship between q and the observed intensities, 
I(q)
89,90
.  The Porod-Debye parameter is the plot of q
4•I(q)  as a function of q4.   The 
plot should display a curve asymptotically approaching a constant value as q becomes 
larger.  The curve for a highly compact structured protein will plateau rapidly at low q 
values.  The curve for a fully unfolded protein would be devoid of any discernible 
plateau.  A protein with a mixture of folded and unfolded regions will have a curve at 
some point in between the two mentioned above.   
 
Research Overview 
 This dissertation focuses on the relationship between SV40 T antigen and its 
binding partners pRb and Cullin7.  Of particular interest is how the structure and 
dynamics of the J domain of T antigen is affected upon protein binding.  These studies 
are aimed at understanding how the J domains participate in the functional activities  
such as cellular transformation of T antigen.  In Chapter II we address the dynamic 
nature of the interaction between the J domain of T antigen and the pocket domain of 
pRb (pRbA/B).  I have approached this question using NMR and SAXS to investigate 
the flexibility of the J domain in the context of the larger T antigen construct, N260, 
30 
 
which contains the J and origin binding domains with a ~30 residues linker between 
them.  Experiments were performed in the absence and presence of pRbA/B.  Protein 
expression, purification and suitable buffer conditions were optimized for the T antigen 
and pRbA/B constructs.  The binding characteristics of T antigen and pRb were 
analyzed.   All NMR data was collected at the Vanderbilt Biomolecular NMR facility.  
All SAXS data were collected at the SYBILS beam line located at Berkley National 
Laboratory by Dr. Michal Hammel.   These studies showed that the dynamic nature of 
the J domain is retained upon binding pRbA/B.  
Studies described in Chapter III identify the residues in the CPH domain of 
Cullin 7 that are significant for the interaction with the J domain of T antigen.  Cullin 7 
is required for T antigen mediated cellular transformation.  This work is aimed at 
determining whether the conserved CPH domain is the binding location for T antigen .  
The binding of the J domain and CPH domain were tested using NMR chemical shift 
perturbation assays.  A weak interaction was found to occur between the two proteins .  
The perturbed chemical shifts were analyzed for significance and the residues identified 
in the interaction were mapped onto the NMR solution structure of the Cul7CPH domain.    
These data suggested a protein surface upon which T antigen could bind.    
 Finally, the data presented in this thesis are discussed in Chapter IV.  Overall, 
my research advances our understanding on how SV40 T antigen interacts with proteins 
of a host cell and provides a foundation for further research on T antigen mediated 
cellular transformation.   
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CHAPTER II 
 
BINDING TO RETINOBLASTOMA POCKET DOMAIN DOES NOT ALTER THE 
INTER-DOMAIN FLEXIBILITY OF THE J DOMAIN OF SV40 LARGE T 
ANTIGEN 
 
 
Introduction 
Simian Virus 40 (SV40), a double stranded DNA polyomavirus, encodes the 
multi-functional multi-domain large T antigen (Tag) protein.  Tag is required at several 
stages of viral productive infection, and is necessary and sometimes sufficient, to  
induce cellular transformation
39
.  During viral infection, Tag is required for the 
initiation and elongation steps of viral DNA replication, transcriptional repression of 
the late viral promoter, regulating cellular transcription, and virion assembly.  SV40 
transforms cells by evasion, inactivation, and deregulation of the growth pathways of 
the host
91
.  It performs these actions primarily through the action of Tag.  
The amino-terminus of Tag is a J domain (Fig. 2.1A), and genetic and 
biochemical studies have established that Tag is a DnaJ molecular chaperone
61
.  DnaJ 
co-chaperones work in concert with DnaK family chaperones.  Tag binds the 
mammalian DnaK homologue Hsc70, and like other DnaJ-DnaK interactions, the 
binding of Tag to Hsc70 leads to activation of the Hsc70 ATPase activity.  The J 
domain and its interaction with Hsc70 are essential for Tag mediated cellular 
transformation
62
.
†
  
†
 This chapter is published: Williams CK, Vaithiyalingam S, Hammel M, Pipas J, Chazin WJ.  
Binding to retinoblastoma pocket domain does not alter the inter-domain flexibility of the J 
domain of SV40 large T antigen. Arch Biochem Biophys. 518(2):111-118 (2012). 
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Figure 2.1.  Domain structure of SV40 Tag (A) and pRb (B), and an overview of the 
chaperone model (C).  Tag binds Rb/E2F complexes primarily via the LXCXE motif, recruits 
its co-chaperone Hsc70, ATP hydrolysis occurs and the complex is disassembled.  
LXCXE Motif 
(103-107) 
One well defined role for the J domain in transformation is the disruption of the 
interaction between retinoblastoma (Rb) tumor suppressor proteins and transcriptional 
activator E2F proteins
92
.  The Rb family contains pRb, p107, and p130 proteins.
i
 These 
multi-domain proteins (Fig. 2.1B) have been implicated in transcriptional activation and 
several other cellular processes
93
.  One function of Rb proteins is to regulate the cell 
cycle by inhibiting proliferation.  Rb is bound to the E2F/DP1 in G1 phase and 
represses its activity
94
.  In late G1 phase, Rb is inactivated via phosphorylation by 
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cyclin dependent kinases, which in turn releases E2F/DP1 and enables entry into the S 
phase and progression of the cell cycle.
95
  Inactivation of Rb causes deregulated E2F 
activity, inappropriate cellular proliferation and may potentia te progression to 
tumorigenesis.
96
 
During both productive infection and cell transformation Tag induces the release 
of E2F transcription factors from the three retinoblastoma proteins, pRb, p107, and 
p130.
64,92
  The release of E2F from Rb is dependent on a functional J domain and 
Hsc70-mediated ATP hydrolysis.
61
  These observations led to a “chaperone” model in 
which Tag first binds to Rb-E2F complexes, and then energy derived from ATP 
hydrolysis by Hsc70, recruited by the J domain, is used to liberate E2F from Rb (Fig. 
2.1C)
97
. 
The chaperone model involves Tag recruiting Hsc70 and multi -protein 
complexes so that the chaperone machinery can alter specific protein-protein 
interactions.  In this model, Tag can alter the target complex by: (1) dislodging specific 
proteins from the complex; (2) altering the conformation and thus the activity of 
proteins in the complex; (3) targeting specific proteins in the complex for post -
translational modification and/or degradation.  This model is consistent with studies of 
Tag action on pRb/E2F complexes, in which it has been shown that energy derived from 
Hsc70-mediated ATP hydrolysis is used to release E2F4 from its association with 
p130.
92
  In the absence of ATP hydrolysis, Tag associates with both Hsc70 and 
p130/E2F4 complexes.
92
  Hence, the assembly of Tag and Rb is a biologically important 
intermediate of the chaperone reaction.  
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If this model is correct, Hsc70 must have the ability to act on different cellular 
complexes, each containing a unique set of proteins.  For example, genetic studies 
indicate that, in addition to targeting Rb-E2F complexes bound near the amino-
terminus, the J domain acts on targets bound in the carboxy-terminal portion of Tag
98
.  
Thus, in each case the J domain must be in position so that Hsc70 is correctly oriented 
relative to the target complex.  This suggests that the J domain must be able to adopt 
multiple orientations relative to the other Tag domains (Figure 1).  This hypothesis is 
supported by cryo-EM studies of Tag
54
, in which the absence of the J domain in the 
structure is presumed to arise from it having different orientations in different 
molecules on the grid. 
Tag binds Rb proteins primarily through a consensus LXCXE binding motif (Tag 
103-107) that resides in the linker between the OBD and the J domain (Fig. 1)
99
.  
However, the details of how Tag coordinates the protein interactions involved in 
inactivation of Rb remains poorly understood.  A crystal structure has been determined 
of a complex of the N-terminal region of Tag containing the J domain and the LXCXE 
motif (N117), in complex with the pocket domain of Rb (pRbA/B)
68
.  The interaction 
interface of Tag in this structure primarily involves the LXCXE motif, but a few 
contacts between the J domain and pRbA/B were also observed.  The chaperone model 
requires that the J domain be able to adopt different orientations in order to correctly 
position Hsc70 for action on its multiple targets.  In contrast, the crystal structure 
suggests the J domain and pRb are in a fixed orientation.  We propose that flexibility 
must exist in the linker between the J and OB domains of Tag to provide the variation 
in positioning required for function.  To test this hypothesis we used a combination of 
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NMR and small angle X-ray scattering (SAXS) experiments to characterize the relative 
flexibility of the linker between J and OB domains, and to determine if this flexibility is 
restricted upon binding to the Rb substrate.  
 
Materials And Methods 
DNA constructs   
A plasmid expressing SV40 Tag construct N260 (4-260) obtained from Professor 
Xiaojiang Chen (University of Southern California) was subcloned into an in-house 
kanamycin resistant pBG101 vector (Dr. Laura Mizoue, Center for Structural Biology) 
containing an H3C cleavable N-terminal 6xHis-GST tag.  The Tag constructs N117 (4-
117) and N102 (4-102) were subcloned from N260 into the ampicillin resistant pET15b 
vector containing an N-terminal 6xHis tag. A pRbA/B (379-570/645-772) construct in 
an ampicillin resistant pGEX-KG vector containing a thrombin cleavable GST tag was 
used in these studies because it corresponds to that used in the crystal structure of the 
pRb-Tag complex.
68
 
 
Protein Expression   
The constructs of SV40 Tag (N260, N117, N102) were expressed in BL21 (DE3) 
Escherichia coli (E. coli) competent cells grown in LB or M9 minimal media containing 
15
NH4Cl and/or 
13
C glucose as needed.  The cells containing N260 were grown at 37 ºC 
and induced with 0.25 mM isopropyl β-D-thiogalactopyranoside (IPTG) overnight at 18 
ºC.  Expression of N117 or N102 was induced with 1 mM IPTG at 37 ºC for 5 hours.  The 
pRbA/B protein was expressed in E. coli XA90 cells.  The cells were grown in Terrific 
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Broth at 37 ºC.  Protein was induced with 0.4 mM IPTG and expressed overnight at 18 
ºC.   All cells were harvested using a JLA 8.1 Beckman rotor at 7000 rpm and 4 ºC for 
20 minutes.  Pellets were stored at -20 ºC.  
 
Protein Purification   
The Tag protein constructs were purified using Nickel affinity chromatography 
(Ni-NTA) in 25 mM Tris (pH 8.0) and 300 mM NaCl.  Cleavage of the His tag on N102 
and N117 was performed with thrombin at room temperature for 3 hrs while the protein 
remained bound to the resin.  The cleaved protein was eluted by washing the resin with 
the purification buffer and followed by size exclusion chromatography (SEC) using a 
Superdex S75 column equilibrated with 20 mM sodium phosphate (NaH 2PO4) (pH 7.2), 
100 mM NaCl, and 5 mM dithiothreotol (DTT).  Cleavage of the His-GST tag from N260 
with H3C protease was performed via overnight dialysis in buffer containing 25 mM 
Tris (pH 8.0), 200 mM NaCl and 2 mM DTT.  A second Ni-NTA purification step was 
used to remove the His-GST tag and the H3C protease.  An elution gradient of 5-20 mM 
imidazole was used to elute the cleaved N260 protein, followed by SEC over a Superdex 
S200 column equilibrated with 20 mM NaH2PO4 (pH 7.2), 100 mM NaCl, and 5 mM 
DTT. 
The pRbA/B protein was purified using glutathione affinity chromatography in 
1X phosphate buffered saline (PBS), 2 mM DTT, pH 7.2 and 10 mM imidazole for the 
elution.  The fusion protein was dialyzed into 20 mM NaH2PO4 (pH 6.0), 50 mM NaCl, 
and 5 mM b-mercapto ethanol (BME).  The GST tag was cleaved at room temperature 
without agitation in the presence of 10% glycerol via addition of  thrombin (100 units) 
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every two hours for eight hours.  Then the cleavage reaction remained at room 
temperature overnight.   The pRbA/B was further purified with ion exchange 
chromatography (SourceS) using 20 mM NaH2PO4 (pH 6.0), 5 mM DTT with a 50 mM - 
1 M NaCl elution gradient.  The final purification step was SEC using a Superdex S200 
column equilibrated with 20 mM NaH2PO4 (pH 7.2), 100 mM NaCl, and 5 mM DTT.   
 
Nuclear Magnetic Resonance Spectroscopy   
NMR experiments were conducted using Bruker DRX 600 and 800 MHz 
spectrometers equipped with z-axis gradient TXI cryoprobes.  All experiments were 
collected at 25 ºC.  To obtain backbone resonance assignments, 800 μM 13C,15N-
enriched N117 was prepared in 1X PBS (pH 6.5), 2 mM DTT and 10% D2O.  The 
experiments acquired were 2D 
15
N-
1
H HSQC and 
13
C-HSQC, and 3D HNCACB, 
CBCA(CO)NH, HN(CO)CA, HNCA, HNCO, 
13
C-NOESY, 3D 
15
N-NOESY, and 
15
N-
TOCSY.  Chemical shift perturbations induced by binding of pRb/AB were elucidated 
by comparing spectra of free 
15
N-enriched N117 and N260 with the corresponding 1:1 
complex with unlabeled pRb/AB in a buffer containing 20 mM NaH 2PO4 (pH 7.2), 100 
mM NaCl, 5 mM DTT, and 5% D2O.  
15
N-
1
H HSQC spectra were acquired for N117 and 
15
N-
1
H TROSY HSQC for N260.  All NMR data were processed using Bruker software 
TopSpin
100
 and analyzed using Sparky
101
. 
 
Small angle x-ray scattering 
SAXS data were collected at the ALS beamline 12.3.1 (SIBYLS) LBNL 
Berkeley, California
102.  The wavelength of the incident beam λ was 1.0 Å and the 
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sample-to-detector distances set to 1.5 m resulting in scattering vectors, q, ranging from 
0.001 Å
-1
 to 0.32 Å
-1
.  The scattering vector is defined as q = 4π sinθ/λ, where 2θ is the 
scattering angle.  All experiments were performed at 20 °C and data were processed as 
described
102
.  The experimental SAXS data for different protein concentrations were 
examined for evidence of aggregation using Guinier plots
103
.  The radius of gyration Rg 
was derived by the Guinier approximation I(q) = I(0) exp(-q
2
Rg
2
/3) with the limits 
qRg<1.3.  The program GNOM
83
 was used to compute the pair-distance distribution 
functions, P(r).  This approach also provided the maximum dimension of the 
macromolecule, Dmax.  In order to determine Rg and Dmax for the OBD and J domain, the 
FoXS server
104
 was used to back-calculate SAXS from coordinates for OBD (PDBid: 
2tbd) and for J domain (N102) (PDBid: 1gh6:A) and this data was then used for Guinier 
and GNOM analyses. 
The recently reported approach based on the Porod–Debye law was used to 
qualitatively assess the presence of structural disorder in the proteins
89
.  The Porod-
Debye law describes a fourth power approximation to the relationship between q and 
the observed intensities, I(q)
90,105
.  Transformation of scattering data as q
4•I(q) vs. q4 
(Porod-Debye plot) should display a curve asymptotically approaching a constant value 
as q approaches infinity.  In practice, the plot for a highly globular protein will plateau 
rapidly at low q
4
 values, whereas the plot for a fully unfolded protein would be devoid 
of any discernible plateau
89
. 
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Computational modeling   
Ab initio shape envelopes were calculated with the program GASBOR
83
.  Ten 
GASBOR runs were merged using DAMAVER.  Overlays with PDB coordinates were 
performed using SUPCOMB using the atomic coordinates from the crystal structures of 
the complex of pRbA/B and N117 (PDBid: 1gh6) and the OBD domain (PDBid: 2tbd).   
Molecular graphics images were generated using PYMOL (DeLano Scientific, Palo 
Alto, CA, USA). 
 
Molecular graphics   
All images were generated using Chimera 1.5.2 (Regents of the University of 
California, San Francisco, CA, USA). 
 
Results 
SV40 Tag is a modular protein containing three globular domains (J, origin 
binding, helicase) and a disordered C-terminal ‘host-range’ domain (Fig. 1).  A segment 
of 29 residues links the J domain to the origin binding domain (OBD).  Previous studies 
have shown the OBD aligns with the helicase domain (HD)
54
.  A crystal structure of the 
J domain and a portion of the linker bound to pRb was reported and identified the 
residues involved in this interaction
53
.  Potential models for the effect of pRb binding 
on the structural organization of Tag domains range from interaction exclusively with 
the LXCXE motif to formation of a tri-partate complex with the J domain and the OBD 
fully engaged.  Differences in these models impact the Tag mechanism of action on pRb 
function, in particular, how the J domain can adjust its orientation to correctly position 
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Figure 2.2.  The J and OB domains of SV40 Large T antigen are structurally independent.  
Overlays of 15N-1H HSQC NMR spectra of N117 (red) and OBD (blue) on the 15N-1H TROSY-HSQC 
spectrum of N260 (black).  Resonances arising from each domain correspond closely to those observed 
in the larger N260 construct. 
Hsc70 for action on its targets.  Our experiments were directed toward investigating 
changes in the relative flexibility of the J domain upon pRb binding.  Since the OBD is 
structurally aligned with the core of Tag
54
, we have selected for our studies a construct 
containing the residues spanning the J domain through the OBD (N260).  
 
The J and OB domains of Tag are structurally independent 
Our approach involved characterizing the structural and dynamic properties of 
the Tag N260 construct first using heteronuclear NMR spectroscopy (Figure 2 .2).  Note 
that TROSY-HSQC, as opposed to the standard HSQC technique was required for the 
larger N260 construct to obtain sufficient resolution of the peaks.  The spectra for all 
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three constructs show well dispersed signals, which is indicative of the presence of 
folded globular domains.  Inspection of these spectra reveals that N 260 has many signals 
that reflect the presence of the J domain and OBD.  In addition, a number of signals  in 
the center of the spectrum are observed, which were attributed to unstructured regions 
including the 29 residue linker between the two folded domains.   
To accurately identify the signals observed in the spectrum of N 260, chemical 
shift assignments for the J domain and OBD are required.  The corresponding NMR 
signal assignments have been reported for OBD
50
 but not for the J domain.  
Consequently, 
15
N- and 
13
C,
 15N
-enriched samples of the J domain N102 and N117 
Figure 2.3.  HSQC spectrum of Tag construct, N117.  The amino acid assignments of the N117  
resonances are labeled.  The insert shows the crowded region around 8 ppm in the 
1
H dimension 
and 120 ppm in the 
15
N dimension. 
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constructs were prepared and a series of standard multi -dimensional heteronuclear NMR 
experiments were recorded (See Materials and Methods).  The assignments for the 
backbone amide resonances of N117 are provided in Figure 2.3.  Note that these include 
the resonances of residues in the linker, including the key LXCXE motif spanning 
residues 103-107. 
Overlays of the individual J domain and OBD spectra onto the N 260 spectrum are 
shown in Figure 2.2.  It is clear from these comparisons that many distinct resonances 
corresponding to the J domain and OBD appear in identical locations in the spectrum of 
N260.  The observation that the J domain and OBD have the same NMR chemical shifts, 
whether alone or tethered together in the context of the N260 construct, indicates that the 
J domain and OBD are structurally independent of each other and implies that the linker 
between them is flexible.   
 
The J domain is flexibly tethered to the OBD 
To test if the tether between the two domains of N260 is flexible, we turned to 
small angle X-ray scattering (SAXS) experiments.  SAXS is well suited for 
characterizing the structural architecture of multi-domain proteins in solution and 
determining whether or not the domains are arranged in a fixed orientation
102
.  Analysis 
of the SAXS data for N260 shows it has a maximal protein dimension (Dmax) and a radius 
of gyration (Rg) (from a Guinier plot, Figure 2.4) of 124 Å and 30.6 Å, respectively.  
These values are significantly larger than the sum of Rg (14.75 + 14.58 = 29.33 Å) and 
Dmax (44.0 + 42.5 = 86.5 Å) values for the two globular domains, calculated from the x-
ray crystal structure of the J domain
53
 and the representative NMR structure of the 
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A 
B 
C 
Figure 2.4.  Guinier analysis of SAXS data for 
N260, pRbA/B and the N260-pRb/AB complex.  
Guinier plots of (A) N260, (B) pRbA/B, and (C) N260-
pRbA/B complex. 
OBD
50
.  More significantly, the 
broadened P(r) function and 
elongation of the P(r) tail (Fig. 2.5B) 
are characteristic of population of 
highly extended conformations where 
the J domain and OBD are far from 
each other.  In addition, the upward 
slope in the Kratky plot at high q 
values (Fig. 2.5A) indicates the 
presence of disordered polypeptide in 
the protein.  In summary, the 
ensemble of the SAXS data indicated 
that the J domain of N260 is flexibly 
attached to the OBD.  
 
pRbA/B interacts with the Tag 
LXCXE motif and the J domain but 
not the OBD 
Binding of pRb to consensus 
LXCXE motifs, including that of 
SV40 Tag, is well established
106–108
.  
The crystal structure of the complex 
of the Tag J domain extended to the 
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LXCXE motif (N117) with pRbA/B revealed a few additional contacts to the J domain
53
, 
although the importance of these contacts to the interaction of Tag and pRb has not 
been directly investigated.  Of importance here, if the contacts with the J domain are 
significant, the binding of pRb may fix the orientation of pRb and J, which has 
implications for the chaperone model.  Following the crystal structure and previous 
studies of Rb binding to LXCXE motif proteins
108
, we utilized the pRbA/B construct 
that contains the core A and B structured domains with a truncated linker.  
An NMR approach was used first to characterize contacts between Tag and pRb.  
Figure 2.6A shows an overlay of the 
15
N-
1
H HSQC spectrum of 
15
N-enriched N117 alone 
(black) and with a 1:1 ratio of pRbA/B (red).  The comparison of these data revealed 
that binding of pRbA/B causes a combination of resonance disappearance, line 
broadening, perturbation of chemical shifts, and some unchanged peaks.  These 
observations are indicative of a direct interaction with pRbA/B that extends beyond the 
LXCXE motif to residues in the J domain.  The perturbation of some but not all signals 
in the J domain is consistent with a specific interaction.  The pronounced broadening 
and disappearance of J domain peaks in the presence of Rb might be interpreted as due 
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Figure 2.5.  SAXS analysis for SV40 Tag N260.  (A) Kratky plot and (B) P(r) function.  
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to the close proximity of the J domain to pRbA/B.  However, given the large size of the 
N117-pRbA/B complex (52 kDa) and the fact that a substantial number of J domain 
signals are present in a basic 
15
N-
1
H HSQC spectrum, the most likely explanation is that 
the J domain does not tumble in synchrony with pRbA/B, which implies that the 
interaction with the J domain is transient.  
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Figure 2.6.  Interaction of pRbA/B with Tag.   (A) Region from the 600 MHz 15N-1H HSQC 
spectra for 15N-enriched N117 acquired in the absence (black) and presence (red) of a 1.0 molar 
equivalent of pRbA/B.  Sequence-specific assignments are provided for the resolved peaks in the 
spectrum.  (B) 800-MHz 15N-1H TROSY-HSQC spectra for 15N-enriched N260 acquired in the 
absence (black) and presence (red) of pRbA/B.  Sequence -specific assignments are provided for 
resolved peaks that are present in the spectrum of the complex, all of which arise from OBD 
residues. 
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Table 2.1.  T antigen residues perturbed 
upon interaction with pRbA/B as 
observed by NMR (black) and X-ray 
crystallography (bold).  
To obtain further insights into the interaction with pRbA/B, we took advantage 
of our NMR chemical shift assignments for the J domain and identified the residues 
whose resonances are perturbed by the addition of pRbA/B (Table 2.1).  
 The disappearance of all of the resonances from the LXCXE motif is consistent 
with it serving as an essential component of the binding interface and with the high 
affinity (Kd 0.44 mM) binding of the isolated 
motif to pRbA/B
50
.  We note that the residues 
whose resonances are perturbed include all of the 
J domain residues that are reported to be in 
contact with pRbA/B in the crystal structure
53
 as 
well as a number of additional residues.  Figure 
2.7 shows a ribbon diagram of J domain with 
these perturbed residues mapped onto the 
structure.  Since residues whose signals are 
perturbed are scattered throughout the J domain and are not clustered near the C-
terminus close to the LXCXE motif, then it is possible to rule out that the perturbations 
are due to simple proximity effects.  Chemical shift perturbations may arise from direct 
inter-molecular contacts or from structural changes induced upon binding of the ligand.  
Hence, it is not possible to determine if the binding site in solution is identical to that 
observed in the crystal structure, but the available evidence suggests this is likely to be 
so.  Regardless, as noted above, the very observation of NMR signals from the J domain 
in this 52 kDa complex strongly implies the interaction between pRbA/B and the J 
domain is more dynamic than implied by the crystal structure.  
T antigen Residues affected by 
RbA/B interaction   
N6; R7; E9; L13; M14; L17; S22; 
I27; L29; M30; R31; K32 Y34; K39; 
E40; G46; G47; E49; K51; M55; 
Y59; K60; K61; G65; G75; G76; T81; 
E82; T85; G87; E90; Y94; N96; A97; 
N99; E100; E101; L103; F104; C105; 
S106; E107; E108; M109; S111; 
S112 
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To determine whether the OBD is also involved in the interaction with pRbA/B, 
an NMR chemical shift 
perturbation assay was 
performed using the N260 
construct.  Figure 2.6B 
shows an overlay of the 
15
N-
1
H TROSY-HSQC 
spectrum of N260 alone 
(black) and with a 1:1 
ratio of pRbA/B (red), 
along with labels that 
identify the origin of the 
resolved resonances.  As described above for the experiment with N 117, the extensive 
degree of peak disappearance and increases in line widths are clear evidence of 
formation of a large complex (69 kDa).  Of critical importance, al l of the assigned 
signals arise from the OBD but none from the J domain.  
This observation does not rule out that the more pronounced broadening and 
disappearance of J domain versus OBD signals in the presence of Rb is simply due to it 
being closer to the Rb than the OB domain.  However, as for the N260-pRbA/B complex, 
the fact that we see signals in a basic 
15
N-
1
H TROSY-HSQC spectrum of this 69 kDa 
complex indicates that the OBD does not tumble in synchrony with pRbA/B.  The most 
likely interpretation of these observations is that the OBD does not interact with 
pRbA/B, but given the limitations of the NMR analysis, it is not possible to rule out 
Figure 2.7.  Map of residues on the J domain whose resonances are 
altered upon binding of pRbA/B.  Ribbon diagram of the J domain 
(PDBid: 1GH6) colored red for residues whose resonances disappear or 
are broadened in the complex (Table 1).  
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alternate explanations such as a highly transient weak interaction with a small OBD 
interface. 
 
The Tag J domain remains flexibly attached to the OBD after pRbA/B is bound.  
To test the effect of pRbA/B binding on the flexibility of N 260, we performed 
additional SAXS experiments on the purified pRbA/B and the complex of pRbA/B with 
N260 (Figure 2.8).  The data for pRbA/B matched well to that previously published
109
.  
The calculated P(r) function of the complex had a Dmax of ~145 Å (Table 2.2) about 20 
Å greater than for N260 alone.  In addition, a new feature in the curve was observed in 
the P(r) function at r ~80 Å, which corresponds to the average distance between the J -
domain and pRbA/B domains (Fig. 2.8B).  
We performed a Porod-Debye analysis for pRbA/B, N260 and their complex to 
obtain direct insights into their relative flexibility 
89
.  In plots of the normalized q
4•I(q) 
vs. q
4
, we find the globular pRbA/B reaches a plateau at lower q than the flexible N 260, 
and the complex is in between (Fig. 2.9).  Table 2.3 lists the Porod volumes  
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Figure 2.8.  SAXS data for the complex of pRbA/B and N 260.  (A) Kratky plot and (B) P(r) 
function. 
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(0.95e
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Rg (Å), 
P(r) analysis 
32.9 27.1 42.2 
 
 
 
 
 
Dmax (Å), 
P(r) analysis 
124 96.5 143.5 
 
 
 
 Porod Vol. (Å
3
) dprotein (g•cm
3
) 
pRbA/B 62000 1.07 
N260 64000 0.78 
N260 - pRbA/B  126000 0.92 
 
Table 2.2.  Comparison of SAXS-derived parameters for N260, 
pRbA/B, and the N260-pRb/AB complex. The error for the Rg 
from the Guinier analysis (in Angstroms) is below the value. 
Table 2.3.  Porod-Debye Parameters derived from the 
SAXS data.  These values are for N260, pRb/AB, and the 
N260-pRb/AB complex. 
51 
 
determined from the three SAXS 
data sets, along with the 
experimental packing densities.  
The ideal value for a compact 
globular protein is 1.37 g-cm
3
.  
The value of 0.8 g-cm
3
 for N260 is 
consistent with extensive inter-
domain flexibility.  Although a 
higher value of 0.9 g-cm
3
 is found 
for the complex, this is still not 
close to the canonical value for a 
compact protein.   
Ab initio molecular 
envelopes were calculated directly 
from the scattering data using 
GASBOR for the free proteins and 
the complex to which the 
corresponding structures were 
manually fitted (Fig. 2.10).  A 
well-defined conformational 
envelope that fits well to the 
coordinates from the x-ray crystal 
structure was obtained for the 
B 
A 
C 
Figure 2.9.  Porod-Debye analysis of SAXS data for 
the N260-pRb/AB complex.  Plots of q4*I(q) vs. q4 plots 
for (A) N260, (B) pRbA/B, and (C) N260-pRbA/B 
complex.   
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Figure 2.10. Molecular envelopes calculated from the SAXS 
scattering data.  Envelope of  (A) pRbA/B alone fitted with the 
crystal structure from 1GH6, (B) N260 alone fitted with the 
structures of the J domain (green - 1GH6) and OBD (orange - 
2TBD), (C) N260-pRbA/B complex. 
globular, single domain 
pRbA/B.  In contrast, the 
scattering data of N260 
alone yielded an 
elongated shape, which 
reflects the highly 
flexible nature of the 
protein.  For the complex, 
the coordinates for 
pRbA/B and the J domain 
fit well into the molecular 
envelope, but the OBD is 
difficult to position, 
which suggests that it 
remains flexibly tethered 
to the rest of the 
complex. This 
observation suggests 
there is little if any global 
compaction of N260 upon 
binding of pRb and that 
the OBD remains flexible, consistent with the NMR results and the upward slope in the 
Kratky plot at high q values for the complex (Fig. 2.8A), indicating the presence of at 
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least some disordered polypeptide.  Together, the data indicate that the Tag J domain 
remains flexibly attached to the OBD when pRbA/B is bound.  
 
Discussion 
SV40 Tag is a modular protein with multiple domains linked by flexible tethers.  
The dynamic nature of modular proteins presents challenges for characterization by 
traditional structural biology approaches.  Here we applied a combination of NMR and 
SAXS to investigate how binding of Rb to Tag affects the structural dynamics of the 
Tag architecture and to determine implications of these data for the evolving chaperone 
model.   
The chaperone model involves Tag recruitment of Hsc70 and multi -protein 
complexes involved in transcription and DNA replication that lead to alterations in 
specific protein-protein interactions.  If this model is correct, the chaperone must have 
the ability to act on different cellular complexes, each containing a unique set of 
proteins.  For example, genetic studies indicate that, in addition to targeting Rb -E2F 
complexes bound near the amino-terminus, the J domain acts on targets bound to the C-
terminus of Tag
98
.  In each case the J domain must be in position so that Hsc70 is 
correctly oriented relative to the target complex.  This suggests that the J domain must 
be able to adopt multiple orientations relative to the other Tag domains.  This 
hypothesis is supported by cryo-EM studies of Tag
54
, in which the absence of the J 
domain in the structure is presumed to arise from it having different orientations in 
different molecules on the grid.  One prediction of the chaperone model is that Hsc70 
directly contacts Rb, E2F or both.  Another prediction of the chaperone model is that to 
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effect release of E2F from Rb, Hsc70 must be positioned to influence the Rb-E2F 
interaction.  
A mechanism for release of E2F/DP1 from Rb has recently been proposed
67
.  Rb 
has structured N terminal and central (pocket) domains as well as an unstructured C 
terminal domain (Fig. 1).  The pocket domain is composed of two structured domains 
(A and B box) connected by a 64 residue unstructured linker.  The transactivation 
domain of E2F binds to the unphosphorylated pocket domain, making critical 
interactions with both the A and B sub-domains.  When phosphorylated, the Rb linker 
binds to pocket domain at the E2F binding site.  The linker can be displaced  from the 
pocket in the presence of the transactivation domain of E2F.  This suggests that there is 
a binding competition between E2F and the pocket linker, which could explain the 
mechanism of Rb inactivation and E2F release.  
Recently, evidence for the direct contact of Hsc70 with E2F has been reported
110
.  
Hsc70 is known to bind unfolded regions of proteins in a substrate binding domain.  An 
unstructured region was observed in E2F and shown to increase stimulation of ATP 
hydrolysis by Hsc70, but only in the presence of a J protein
110
.   This suggests that the J 
domain is required to attain proper positioning of Hsc70 for contact with the E2F 
substrate.   
These observations and our results support the chaperone model and highlight 
the intrinsically dynamic nature of the protein complexes.  Our data has shown that the 
J domain is structurally and dynamically independent of the other Tag domains.  This 
provides a required degree of flexibility for altering the spatial localization of the 
Hsc70-Tag-Rb complex to drive the dissociation of E2F transcription factors.  In 
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particular, despite binding of both Hsc70 and Rb, the residual dynamics can allow 
positioning Hsc70 for direct contact with E2F yielding an increased rate of ATP 
hydrolysis and disassembly of the entire complex, which would lead to improper 
progression of the cell cycle.   
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CHAPTER III 
 
TOWARD STRUCTURAL CHARACTERIZATION OF SV40 T ANTIGEN J 
DOMAIN WITH THE CULLIN 7 CPH DOMAIN 
 
 
Introduction 
 The SV40 T antigen protein is capable of transforming a variety of cells and 
inducing the formation of tumors in animal model.  T antigen is a multi -domain, mulit-
functional protein that depends upon binding and strategically inactivating proteins of 
the host cell that regulate the growth cycle.  It inactivates the tumor suppressor proteins 
of the pRb family as well as p53.  Over the years, T antigen research has focused on 
determining the mechanisms by which it transforms a cell.  This has led to the 
discovery of other proteins that are bound by T antigen.  The mammalian cullin family 
protein, Cul7, is one of those reported to be associated with T antigen.  
 The cullin RING ubiquitin ligase (CRL) protein family is the largest class of 
ubiquitin ligases, which are critical for the regulation of protein degradation.  Proper 
degradation of proteins is important for many cellular processes, including transcription 
and signal transduction.   CRL proteins are involved in the regulation of these 
proceses
111,112
.  In mammalian cells, there are at least six cullin proteins that have been  
identified (Cul1, 2, 3, 4a, 4b, 5 and 7).  They all contain the conserved cullin homology 
domain.  Cullin forms a scaffold for mulit-protein complexes called SCF (Skp, Cullin, F 
box) that carry out ubiquitination of target substrates.  Cullins are activated by the 
ubiquitin like molecule Nedd8, which leads to the binding of a RING containing protein 
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such as Rbx1/Roc1 and recruitment of a ubiquitin conjugating enzyme to the SCF 
complex
113
.  The cullin of interest in this work is Cul7.  
 In 1992, D. Kohrman and M. Imperiale reported that SV40 T antigen formed a 
stable complex with a 185 kDa host cell protein
114
.  While using co-immuno-
precipitation experiments to characterize T antigen-pRb complexes in rodent cells, this 
protein (p185) was pulled out of solution with the complex.  The association of this 
mystery protein with T antigen was independent of pRb or p53 binding.  While working 
with truncated version of the T antigen protein, the binding of p185 was localized to 
residues 1-121, which contains the J domain.  Additionally, the deletion of residues 2-
108 from T antigen abrogated binding to the 185 kDa protein.  This suggests that the J 
domain is important for the binding of this protein and is likely to be functionally 
important, as well
114
.  
In 2000, Tsai et al. discovered a 193 kDa protein binding to T antigen via the J 
domain
115
.  Mutation of T antigen residues 107 and 108 did not affect the binding 
implying that this interaction is independent of pRb binding.   The size and binding 
similarities hinted that this may be the same as the 185 kDa protein.  Sequence analysis 
revealed that the protein contains an LXCXE motif, the consensus binding sequence for 
pRb proteins, at residues 1052-1056.  This protein also contained a Bcl-2 homology 3 
(BH3) domain at residues 1556-1572, which is associated with proteins that promote 
apoptosis.   Fluorescence studies found that this protein promoted cell death during the 
G1 phase before the onset of DNA synthesis.  Co-expression of the 193 kDa protein 
with T antigen inhibited its ability to induce cell death.
115
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 In 2004, Ali et al. identified that the 185 kDa and 193 kDa proteins were all the 
recently characterized cullin protein, Cul7
113,116
.  Their research recapitulated the 
previous findings that Cul7 binds to T antigen via the J domain.   T antigen residues 69-
83 are particularly important for the binding of Cul7
117
.  Cul7 binds T antigen in a 
manner independent of pRb, and p53.   The binding of Cul7 also did not disrupt T 
antigen mediated viral DNA replication.  However, T antigen protein that is defective 
for binding of pRb or Cul7 could not support cellular transformation.  This suggests 
that Cul7 has a role in cellular transformation.  Cul7 also bound to the traditional cullin 
protein, Rbx1/Roc1 and F box proteins, Fbx29 and Fbw6
113,116
.   
At this time, the targets of Cul7 were unknown.  Subsequent research has shown 
that Cul7 targets cyclin D1, a regulator of the G1/S phase cell cycle transition, and 
insulin receptor substrate-1, a mediator of the insulin/insulin-like growth factor 1 
signaling system
118
.  Dysregulated Cul7 is directly linked to the autosomal recessive 
diseases 3-M and Yaktus because Cul7 mutations were identified in families with these 
conditions.
118,119
  There are 25 Cul7 mutations associated with 3-M patients alone
119
.  
The phenotype of both diseases is pre- and post-natal growth retardation
118
.  The 
association of Cul7 with these proteins and diseases suggests that it may play a role in 
cell cycle progression, senescence and growth control.   
When Cul7 is compared to its other family members, some distinctive features 
are seen.  Cul7 has been shown to be present only in vertebrates.  The human Cul7 is 
1698 amino acids which makes it larger than its sister cullins
118
.   Besides the conserved 
cullin domain, Cul7 has a DOC domain that is involved in ligand binding and a CPH 
(conserved in Cul7, PARC and HERC2 proteins) domain.  A schematic diagram of the 
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Cul7 domains can be seen in Figure 3.1.   Other cullins tend to only interact with 
proteins within the 
context of the SCF 
complex; however 
Cul7 stably 
interacts with 
proteins like p53 
and T antigen.   
The interaction of 
Cul7 with these proteins has garnered much interest because these associations imply 
that Cul7 is involved in cellular growth processes and is therefore a possible therapeutic 
target. 
The p53 tumor suppressor protein is inactivated in many cancers , so detailed 
insight into the mechanisms of its regulation has been a research focus for many years.  
Cullin E3 ligases typically participate in the degradation of a protein target.  Cul7 does 
support the mono- and di-ubiquitination of p53 but there is no evidence that it promotes 
p53 degradation.
118,120,121
  Reports show that p53 is required after DNA damage to 
upregulate the Cul7 mRNA and protein levels, which may suggest this interaction has a 
role in transcriptional regulation
120
.  In a functional screen, Cul7 prevented apoptosis 
and promoted the transformation of neuroblastoma cells in a p53 dependent manner
122
.  
More research must be done to confirm that Cul7 regulates apoptosis.  To better 
understand the structure, interaction and function of the Cul7-p53 binding, the 
Arrowsmith laboratory turned to solution NMR spectroscopy studies
123
.  NMR 
Figure 3.1. Domain organization of Cullin 7.  This E3 ligase contains a 
CPH domain (yellow) through which it binds p53; a DOC domain (orange) 
involved in ligand binding, the conserved cullin domain (blue), and 
possibly a region through which the post -translational modification, 
neddylation, may occur (green). Adapted from Sarikas et al.  
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experiments revealed that the CPH domain (360-460) of Cul7 binds to the 
tetramerization domain of the p53 protein.  They also determined a structure of the CPH 
domain (Figure 3.2).  The CPH domain 
has a β-barrel tertiary structure 
consisting of three loops, five 
antiparallel β-strands, and an α-helix.  
The CPH domain was deemed necessary 
and sufficient for p53 binding
124
.  As 
mentioned previously, T antigen binds 
and inactivates p53.  As the SV40 virus 
takes over a cell, the various roles of 
Cul7 make it an attractive protein for T 
antigen to target and usurp.   
The Cul7 protein binds to the J 
domain of the T antigen protein.  The critical T antigen residues (69-83) for that 
interaction have been identified.  The goal of this research study was to determine the 
location on Cul7 to which the J domain binds.  The Fanning laboratory performed yeast 
two hybrid experiments that implicated the CPH domain as the binding site f or T 
antigen (E. Fanning, personal communication).  The molecular weights of the J and 
CPH domains (11.7 kDa and 11.5 kDa, respectively) make them readily amenable to 
NMR spectroscopy.  Hence, NMR chemical shift perturbation assays were used to 
verify the interaction between the J and CPH doamins and to determine which Cul7 
residues are involved in the binding interface.   
Figure 3.2. Structure of the Cul7 CPH domain. 
The CPH domain contains and alpha helix 
(yellow) and four beta sheets (orange).  
PDBid:2JNG. 
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Materials And Methods 
Cloning 
 The pET15b plasmid containing Cul7CPH was received from the Fanning 
laboratory. Primers were designed to clone T antigen construct N102 containing residues 
(4-102) which span the functional J domain.  For the N102 fragment, the forward primer 
(5’-GGGAATTCCATATGGTTTTAAACAGAGAG-3’) contains a Nde1 restriction site 
and ATG start codon. The reverse primer is (5’-
CCGCTCGAGTCAGTTTTCCTCATTAAAGGC-3’) contains an Xho1 restriction site 
(underlined) and either TTA or TAA stop codon.  For the N117 construct (4-117), the 
forward primer is the same as the N102 forward primer.  The reverse primer is (5’-
CCGCTCGAGTCAAGTAGCCTCATCATC-3’).  The restriction enzymes used were the 
same as for N102.  Both constructs were cloned into the pET15b vector which contains a 
thrombin cleavable 6X-His tag. 
  
Protein Expression   
 The pET15b plasmid containing N102 or Cul7CPH was transformed into 
BL21(DE3) competent cells.  The unlabeled protein was prepared using LB medium 
containing ampicillin (100 mg/mL) and grown at 37 °C with shaking until OD600 
reaches between 0.5-0.9.   Protein expression was induced with IPTG to a final 
concentration of 1 mM and continued for 3-5 hrs at 37 °C with shaking.  The expression 
profile of Cul7CPH can be seen in Figure 3.5.  The culture was centrifuged at 7 K rpm 
for 20 minutes and the resulting pellet was stored at -20 
o
C.  Uniform 
15
N- labeled 
proteins were produced similarly, except for using M9 media enriched with 
15
NH4Cl.  
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Protein Purification 
 The purification of N102 and Cul7CPH proceeded in the same manner.  The cell 
pellet was resuspended with a protease inhibitor tablet in 25 mL of the following buffer: 
25 mM Tris at pH 7.5, 250 mM NaCl, 2 mM DTT.  The lysate was sonicated for 5 
minutes (5 sec on; 5 sec off) and then centrifuged at 20K rpm for 20 minutes.  The 
lysate was filtered and incubated with 5 mL column volume of NiNTA resin for 20 
minutes.  The column was then drained and washed with 20x column volume of the 
above buffer.  The 6xHis tag was cleaved by mixing 10 units (1unit/uL) of thrombin 
with one column volume of buffer and adding it to the column.  The slurry of resin 
bound protein and thrombin are then incubated with rocking at 4
o
C for 4 to 8 hours. The 
cleaved protein was then drained and the column washed with 5 column volumes of 
buffer to remove any remaining cleaved protein.     
 
Isothermal Calorimetry 
Isothermal Calorimetry (ITC) responds to changes in heat evolution as molecules 
interact.  Titration of a binding partner into the sample cell containing the protein of 
interest allows for a binding curve to be generated.  ITC was performed to investigate 
the interaction between the T antigen construct N102 and Cul7CPH.  Both samples are 
purified in a buffer containing DTT.  A buffer containing DTT cannot be used during 
ITC experiments, however BME is allowed.  So, the protein samples were dialyzed into 
25mM Tris at pH 7.5 and 250mM NaCl and then into 25mM Tris at pH 7.5, 250mM 
NaCl, and 1mM BME.  The N102 was concentrated to ~750 μM and Cul7CPH to ~30 μM.  
The Cul7CPH was placed in the sample cell and N102 was injected during the experiment.  
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The data was collected at 25 ºC using a MicroCal VP-ITC and analyzed using the 
manufacturer’s software.  
  
 Dynamic Light Scattering 
Dynamic Light Scattering (DLS) measures the intensity fluctuations of scattered 
light arising from the random motions of a particle in solution (ie. Brownian motion).  
The Brownian motion is inversely proportional to size therefore the size of the molecule 
can be deduced.  This technique was used to determine whether N102 was monomeric or 
forming some higher order oligomer.  The buffer used for this experiment was 25mM 
Tris at pH 7.5, 250mM NaCl and 1mM BME.  The concentration of N102 used for the 
DLS experiment was 75µM.   
 
NMR Chemical Shift Perturbation Assays 
 All NMR titration experiments were performed on the 500 MHz Bruker 
spectrometer equipped with a cryoprobe and operating at 25 °C.  Two-dimensional 
15
N-
1
H-HSQC spectra were acquired on 
15
N-enriched samples of Cul7CPH in 90% H2O/10% 
D2O, and in the presence of unlabeled N102 titrated to assess the interaction and to map 
the binding surface.  The buffer used for the NMR titration experiments was 100 mM 
NaCl, 25 mM Tris and 2 mM DTT at pH 7.5.  The ratio of unlabeled N102 to 
15
N-
Cul7CPH used in this experiment was 1:30 with 
15
N-Cul7CPH at 100 uM and N102 at 3 
mM.  Because of the high ratio, a cross titration method was used in this experiment so 
that the volume of the sample would not significantly change and thus dilute the 
15
N-
Cul7CPH concentration.  Two NMR samples were prepared.  One contained only 
15
N-
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Cul7CPH at 100 uM and the other contained the 1:30 concentration of 
15
N-Cul7CPH:N102.    
A two-dimensional 
15
N-
1
H-HSQC spectrum was collected for each sample.  To obtain 
the points between the zero and high concentrations of N102, 50 μL was removed from 
each sample, put into the other, vortexed to fully mix and then spun down to release any 
bubbles.  Then 
15
N-
1
H-HSQC spectra were collected for the new samples.  The 
exchange was performed multiple times and the concentration of these middle points 
was calculated.  Figure 3.3 provides a schematic diagram of this technique and a listing 
of all the titration points in this experiment.   All NMR data were processed using 
TOPSPIN (Bruker Biospin Ltd.) and analyzed using Sparky (University of California, 
San Francisco).   
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1:0                    
1:3                    
1:7.8                 
1:9.2                 
1:11.6               
1:12.3               
1:12.9               
1:13.3               
Titration Points 
B 
1:16.9 
1:17.3 
1:17.8 
1:18.5 
1:20.8 
1:22.2 
1:27 
1:30 
Figure 3.3. NMR Titration of N
102
 
into
15
Cul7
CPH
.  A. Schematic diagram of the 
titration method. B. List of the titration points 
collected 
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Results 
Production of N102 and Cul7CPH protein 
In order to characterize the CPH domain of Cul7 and the putative changes that 
occur upon binding of the T antigen J 
domain, production of pure protein for 
NMR spectroscopy studies was 
necessary. The T antigen construct N102 
was successfully subcloned, expressed 
and purified using NiNTA affinity 
chromatography.  Figure 3.4 shows the 
high yield of unlabeled N102 protein 
from one liter of cell culture directly 
after the NiNTA affinity 
chromatography step.  The expression 
of unlabeled Cul7CPH was low (Figure 
3.5), which leads to even lower expression of 
15
N-enriched protein (Figure 3.6).  From 2 
liters of cell culture, the protein yield is ~2 mg/mL.  While producing enough protein 
was the rate limiting step, once produced the protein is stable at 4  ºC.  However, the 
poor yield only allows for only a uni-directional NMR titration where Cul7CPH is the 
protein kept at a constant concentration.  This purified protein was used for ITC and 
NMR experiments. 
 
Figure 3.4.  Purified N
102
 protein. This SDS gel 
is of 1L of unlabeled protein. Lane 1 is the 
molecular marker. The remaining lanes contain 
purified protein.   
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The J domain of T antigen is monomeric and folded in solution 
Dynamic light scattering (DLS) measurements were used to characterize the 
oligermeric state of the J domain construct N102.  The DLS sample contained N102 at a 
concentration of 74 uM.  Analysis of the spectrum revealed a single peak at ~12 kDa 
which corresponds to the molecular weight of N102 of 11.4 kDa (Figure 3.7).  NMR 
spectroscopy was used for further characterization of the J domain construct.   
Optimization of NMR spectral conditions, which involved testing various buffers, 
temperature and pH conditions, was primarily performed on the longer J domain 
construct (N117) but was also applied to N102.  Circular dichroism (CD) spectroscopy, 
(data not shown), used to evaluate the secondary structure of the J domain, was 
performed on the N117 construct, as well.   The buffer considered best for collection of J 
 
Figure 3.6.  SDS Purification gel of 2L of 
15
Cul7CPH. The first lane contains the molecular 
weight marker.  The second and third lanes are the 
beads prior to protein load and the flow through, 
respectively.   Lanes four and five are washes done 
to remove unbound proteins. Elutions containing 
purified Cul7CPH are highlighted in the black box.  
Cul7
CPH       
Post Pre  
 
Figure 3.5. E-coli expression of 
Cu7
CPH
.  Lane 1 of this SDS 
PAGE gel is the molecular marker. 
Lane 2 is the protein expression 
post IPTG induction.  Lane 3 is 
pre-induction protein. 
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Figure 3.7.  Dynamic Light Scattering of N
102
.  The DLS results showed two peaks.  The smaller 
peak at 7 kDa corresponds to the signal from the solvent.  The larger peak at 11 kDa is that of protein.  
The presence of a single protein peak shows that N
102
 is monodisperse in solution.  
domain NMR spectrum consisted of 50mM Na2HPO4 at pH 6.5, 100mM NaCl and 2mM 
DTT.  A protein concentration of 200uM was used to collect two-dimensional HSQC 
spectra for each construct (Figure 3.8).  A total of 87 peaks can be distinguished for the 
N102 protein and 97 peaks for N117.  These peaks were well dispersed across the 
spectrum which is an indication of a well-folded protein.   The spectrum of N102 could 
perfectly overlay on the spectrum of the longer N117 protein, which confirms that the 
solution conditions for one can be used for the other.  The peaks belonging to the extra 
residues in N117 could be clearly seen in the central region of the HSQC suggesting that 
they are unstructured and flexible.  
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Toward the biophysical characterization of T antigen/Cullin7 interaction 
 As previously mentioned, unpublished yeast two-hybrid experiments were 
performed in the Fanning laboratory.  The yeast two-hybrid technique measures protein-
protein interactions by measuring transcription of a reporter gene. If protein X and 
protein Y interact, then their DNA-binding domain and activation domain will combine 
to form a functional transcriptional activator (TA).  The TA will then proceed to 
transcribe the reporter gene that is paired with its promoter  yielding colony formation.  
Figure 3.8. Overlay of HSQC spectra for the J domain constructs .  Orange: HSQC 
spectrum of N117; Purple: HSQC of N102 
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The Fanning lab tested the binding of N102 construct with Cul7CPH along with full length 
T antigen with p53 and laminin as positive and negative controls, respectively (Table 
3.1).  Their research indicated that the J domain of T antigen may bind Cul7 via its CPH 
domain.  
Binding 
Domain 
Activation 
Domain 
Colony Growth 
p53 (positive) Tag (full length) Yes 
Laminin (negative) Tag (full length) No 
Cul7(360-433) Tag (4-102) Yes 
 The region on T antigen that Cul7 binds has been structurally characterized. This data 
prompted the structural investigation of the location on Cul7 at which T antigen 
interacts.  
 The first step towards attaining a more detailed understanding of the Cul7 
interface for T antigen binding was to perform ITC experiments.  Due to the low protein 
yield of Cul7CPH, 50 μM Cul7CPH (360-460) was placed in the ITC sample cell at 25 ºC 
and 1 mM of N102 was titrated into the cell.  Both proteins were in an identical buffer, 
which contained 25 mM Tris (pH 7.5), 250 mM NaCl, and 1 mM BME.  Unfortunately, 
we did not observe any heat evolution that would allow fitting of the data to a binding 
model and calculating the dissociation constant (Figure 3.9).  While the results of ITC 
showed no observable heat evolved during the titration of N102 into Cul7CPH, this does 
Table 3.1. Yeast two-hybrid of T antigen (N102) with Cullin7 (CPH domain).  
The results indicate that there is an interaction between  the CPH domain of                        
Cul7 and the J domain of T antigen.  
*Results from the Fanning laboratory at Vanderbilt University.  
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Figure 3.9.  ITC experiment of Cul7CPH 
with N102. The ITC curve was linear which 
shows that an interaction was not observable 
by ITC. 
not necessarily rule out binding, but is simply indicative of a low ΔH of the reaction .  A 
more sensitive technique, like NMR spectroscopy, was needed to continue the 
characterization of this interaction.  
 
Mapping the Cul7CPH binding surface utilized by the J domain of T antigen 
 The solution structure of Cul7CPH was previously determined using NMR 
methods by the Arrowmith laboratory and the assignments were deposited in the 
BMRB
123
.  This structure and the 
assignments were used in combination 
with NMR titration data to map the 
Cul7CPH surface involved in the 
interaction with the J domain of T 
antigen.  NMR is a powerful structural 
technique that has proven useful in the 
study of protein-protein interactions
125
.  
Performing an NMR chemical shift 
perturbation assay is the most common 
method to study protein interactions.  In 
this assay, a two dimensional HSQC is 
collected on an 
15
N-labeled protein.  An 
unlabeled binding partner is then added 
to the sample containing the 
15
N-labeled protein at predetermined concentrations.  
Additional HSQC spectra are recorded after each addition of the unlabeled protein.  The 
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chemical shift is a parameter that is very sensitive to changes in environment.  If an 
interaction has occurred, the peaks corresponding to residues at the binding interface 
will be perturbed.  Peak perturbations can either be a change in the location of the peak 
or a decrease in its intensity.  Changes in the structure of the protein upon an 
interaction will also produce chemical shift perturbations.  When a high resolution 
structure and the corresponding resonance assignments are known, the binding interface 
can be accurately identified and mapped onto the structure. 
 As previously mentioned, the initial step is to obtain a spectrum of the 
15
N-
labeled protein alone in solution, in this case Cul7CPH.  The HSQC spectrum of Cul7CPH 
was collected in 25 mM Tris (pH 7.5), 250 mM NaCl, and 2 mM DTT (Figure 3.10).   
This spectrum showed well dispersed signals, which indicates that Cul7CPH is a well 
folded domain and suitable for further NMR experiments.  The chemical shifts in the 
Figure 3.10.  HSQC spectrum of Cul7CPH. The peaks are dispersed across the spectrum 
which confirms that this is a well folded protein.   
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spectrum were quite similar to the previously assigned Cul7CPH resonances and could be 
transferred onto the peaks in this spectrum
123
.  A total of 95 of the 101 peaks of the 
Cul7CPH (360-360) were unambiguously assigned. 
 Collection of the initial spectrum was followed by establishing the titration 
conditions.  The first NMR titration performed at points along the concentration range 
of 0:1 to 6:1 ratio of N102:
15
Cul7CPH.  This 
experiment did not reveal significant chemical shifts 
so collecting higher titration points was necessary.    
Hence, the NMR titration experiment was re-
structured to contain just three points: 0:1, 5:1 and 
20:1.   The buffer was modified to contain 100 mM 
NaCl, 25 mM Tris at pH 7.5, and 2 mM DTT from a buffer that contained 250 mM 
NaCl.  The final concentrations of the protein stock solutions were 11.5 mM for N102 
and 250 µM for 
15
Cul7CPH.  From the 
15
Cul7CPH stock, a 100 µM NMR sample was 
prepared.  After the NMR spectra were collected and processed, the 20:1 spectrum was 
overlaid upon the 0:1 spectrum.  There were some obvious chemical shifts and intensity 
changes in several of the resonances.  These resonance perturbations were matched to 
the chemical shift assignments (Table 3.2).  A few of the residues perturbed are also 
changed upon the binding of Cul7 to p53
123
.  The results of this analysis suggest that J 
domain may occupy the same or similar binding site as p53. 
Cul7CPH residues perturbed 
upon N102 binding 
Y372; D375; L377; Q378;   
E391; R401; S403; N404;  Q411; 
E429; W422; H424 
Table 3.2. Residues perturbed 
during 20:1 N102:
15
Cul7CPH NMR 
titration. Residues in red were 
perturbed upon binding p53 as 
reported in Kaustov 2007. 
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To obtain detailed structural information regarding the T antigen/Cullin7 binding 
interface, the NMR titration experiment was restructured and performed once again.  As 
increasing amounts of a binding partner is added, the volume of the sample is increased  
and the concentration of the 
15
N-labeled protein is diluted.  The titration experiment 
designed to combat this problem has been described in the Experimental Methods 
section.  Briefly, the final concentration for each protein stock used in this experiment 
was: [N102] = 6 mM and [
15
Cul7CPH] =338.8 µM.  Two NMR samples were prepared.  
One contained just 100 µM 
15
Cul7CPH (ratio 0:1) while the other contained 3 mM N102 
and 100 µM 
15
Cul7CPH (ratio 30:1).  A one-dimensional NMR spectrum was collected 
on the 30:1 (N102:
15
Cul7CPH) sample and on a 50 µM NMR sample from the unlabeled 
Figure 3.11.  Overlay of NMR titration spectra. HSQC of titration point 0:1 (purple); HSQC 
of titration point 30:1 (orange)  
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N102 protein stock to ensure that protein was present and properly folded.  The 
experiment continued with the collection of two-dimensional HSQC spectra for each 
titration point.  An overlay of the 30:1 spectrum onto the 0:1 spectrum can be seen in 
Figure 3.11.  This overlay shows that there were selective changes in intensity of 
certain peaks as well as definite perturbations of chemical shifts.  This data highlights 
that a binding interaction has occurred.  However, the large amount of N102 required to 
elicit the modest peak shift indicates that the interaction is weak.   
The significance of the observed residue perturbations were evaluated and 
measured.  The average change in chemical shift of all the residues  was calculated 
using the following formula: Δδ = [(0.17ΔδN)2 +  (ΔδHN)2]1/2126.  The results of this 
calculation can be seen in Figure 3.12.  Residues that have a chemical shift change 
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Figure 3.12.  Plot of the average change in chemical shift.  The red line shows 
approximately where the standard deviation, 0.0338 is located. 
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Table 3.3. The list of the residues with significant perturbations.  Only residues greater than  
standard deviation were considered in the rest of the analysis.  
greater than the standard deviation (std. dev. = 0.0338) may be significant in the 
binding interaction.  The calculation was applied to all of the Cul7CPH residues (360-
460), however only residues until residue 435 were plotted.  The PDB structure of 
Cul7CPH includes only residues 360-435 because residues 436-460 were determined to 
be disordered
123
.   The residues with significant perturbations are listed in Table 3.3.  
Only the residues above the standard deviation (those in the yellow and green columns) 
were considered for further analysis. 
Red Yellow Green Average change in chemical shift: 0.028119 
E362 R360 Q378 Standard Deviation: 0.033818  
F363 V373 A394    
D388 L371 F400 Residue Range  
D436 D375 N404 Red: 0.028119 - 0.033818  
M440 G380 F413 Yellow:  0.033818 - 0.08   
V450 Q402 H426 Green: 0.08 and above  
V454 W414 Q447 Significant residues after structure ends  
 
W422 
 
Residues that may not be significant  
 
L431 
 
  
 
G432 
 
  
 
E438 
 
 
 
D439 
 
 
Y441 
 
 
E442 
 A443 
The change in chemical shifts, in both the 
15
N and 
1
H dimensions, was then 
plotted against the different concentrations of N102 for each of the significant residues, .  
This leads to the identification of residues that showed erratic chemical shifts that are 
not due to the binding event.  The charts for the analysis of the amide and proton 
chemical shifts are in Figure 3.13.  For example, the residue, Q378 showed an 
77 
 
inconsistent chemical shift pattern which is not likely due to the binding event so it  was 
withheld from further analysis.  The other residues showed a consistent change in 
chemical shift as the concentration of N102 was increased.  This data confirmed that 
some of the residues involved in binding p53 (ie. N404 and W422) are also involved in 
binding the J domain of T antigen.  However, there are many differences , which suggest 
that T antigen may not bind in the exact same manner as p53 but rather it occupies a 
similar surface.  The residues of the Cul7CPH domain that displayed significant 
perturbation upon binding to N102 were mapped onto the NMR solution structure of the 
domain (Figure 3.14). While there are not a lot of residues that were significantly 
perturbed, they do appear to occupy a common region on the CPH domain.  The 
perturbed residues reside on either side of a central channel formed by a flexible region 
and a beta sheet.  These studies have provided insight into the T antigen binding site on 
Cul7.  However, further experiments are required to gain additional insights into the 
precise mechanism of binding. 
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Figure 3.13.  Plot of the change in chemical shift .  The changes in the amide (top) and proton 
(bottom) dimensions, plotted against the residues identified as significant, against the concentrations of 
N102.  Q378 was eliminated as a significant residue.  
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Discussion 
 The role of SV40 T antigen is to utilize or usurp proteins in a host cell for the 
intention of producing a deregulated and transformed cell.  Cullin7 is an E3 ligase that 
can mediate protein degradation.  The binding interaction of T antigen to Cullin7 has  
been established in the literature
113,124
.  It has been demonstrated that this interaction is 
essential for cellular transformation
113
.  It is believed that T antigen induces cellular 
transformation by utilizing its function as a chaperone protein.  This need for Cullin7 
suggests it may have a role in the T antigen chaperone mediated protein inactivation for 
the propagation of the SV40 virus and cellular transformation. 
 Mutational studies identified T antigen residues 69-83 as the binding surface for 
Cul7.  These residues are located in the J domain of T antigen  and their deletion 
abrogates its ability to bind Cul7 but not its ability to association with p53 and pRb
124
.  
F
i
Figure 3.14.  Structure of Cul7CPH. A. Red- the residues significant in the binding of J domain to Cul7.  
B. Solid surface representation.  Note: Figures are in the same orientation. PDBid: 2JNG 
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The deletion of these T antigen residues also reduces its cellular transformation 
abilities.  Our study was designed to identify the putative binding region on Cul7 that is 
required to bind T antigen.   
 The literature has identified the CPH domain in Cul7 as sufficient for binding to 
the tumor suppressor protein p53.  This domain is conserved, which suggests that it has 
an important role.  Since the CPH domain is already known to be a protein binding 
domain, it was proposed that T antigen may bind there as well.  The role of T antigen is 
to disrupt the regular functions of cellular proteins.  Therefore occupying a binding 
surface that belongs to a host protein could definitely cause a disruption in the normal 
cellular processes.   
A biochemical and structural approach was used to investigate the J and CPH 
domain interaction.  The results indicated that a weak interaction had formed between 
the two domains.  The weak binding may speak to the mechanism of the function or 
indicate that some additional residues outside the CPH domain and/or other host cell 
proteins may be involved to strengthen the interaction.  In the study of the p53-Cul7CPH 
domain interaction the affinity was also weak (~530 μM)123.  However, when compared, 
the affinity of p53 was greater for the full length protein than for the CPH domain 
alone
123
.  This may hold true for the binding of T antigen as well.   
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In mapping all of the residues involved in this interaction onto the structures of 
the J and CPH domains, a possible mode on binding is revealed (Figure 3.15).  The T 
antigen J domain residues involved in binding Cul7 are on the loop between the third 
and fourth helices. The CPH domain residues demonstrated to be involved in the 
interaction surround a central channel in the structure.  It is possible that the T 
antigen/Cullin7 mechanism of interaction occurs via the insertion of the J domain loop 
into the central region of the CPH domain.  It is probable that this is a highly dynamic 
interaction involving other proteins of the host cell.  As mentioned previously, the 
binding of Cul7 to T antigen does not disrupt pRb or p53 binding.  These proteins, 
along with the co-chaperone of T antigen Hsc70 may be present.  It would be useful if a 
Figure 3.15.  Mode of T antigen and Cullin 7 binding.  The structures of the T antigen J domain 
(left, 1GH6) and Cul7CPH (right, 2JNG) have the known interacting residues highlighted in blue and 
red, respectively.  The yellow arrow signifies the loop of the J domain could insert into the cavity in 
Cul7CPH. 
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stable complex of T antigen, Hsc70 and pRb or p53 could be formed and viewed by 
SAXS to determine their orientation in solution.  On a smaller note, performing the 
reverse NMR N102/Cul7CPH titration would allow structural verification of the involved 
residues on T antigen.  It would also reveal whether the Hsc70 binding site, the HPD 
tripeptide, is perturbed upon binding.  The protein expression and purification of 
Cul7CPH would have to be optimized to accommodate a reverse titration.  Cullin 7 also 
has an LXCXE sequence, which is the Rb family consensus binding motif.  NMR 
titration experiments could be used to investigate whether Cul7 is able to bind Rb 
proteins.  If Rb does bind, how its interaction with Cul7 changes in the presence of T 
antigen would be interesting.  Further structure based studies coupled functional 
studies, involving mutating the amino acids at the binding interface and growth assays 
would provide more insight into the mechanisms by which T antigen transforms cells  
and participates in the regulation and growth of cells.    
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CHAPTER IV 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
 
Research Summation 
 
The role of the Tag in cell transformation 
 SV40 T antigen is a complex multi-functional protein that binds to various 
cellular proteins. The complexity of Tag compensates for the simplicity of the SV40 
genome, which does not contain the necessary components to self -replicate.  The virus 
depends heavily on the host cell but the genome does contain regulatory signals that 
direct Tag production.  As the concentration of Tag grows, the protein binds to the 
origin region of the virus genome, which initiates DNA replication.  In order for viral 
replication to occur, it is important that the host cell enters S phase.  In S-phase, the 
viral genome is replicated along with the host cellular genome. Binding host proteins, 
such as DNA polymerase-α and inactivating tumor suppressor proteins, such as pRb, 
allows for the cells to enter S-phase, promoting DNA replication and viral propagation.  
Tag mediated inactivation of tumor suppressor proteins, supersedes the inhibition of 
cell growth yielding more opportunities for viral production
127
.  While, the primary goal 
of Tag is to induce production of additional SV40 particles, cellular transformation is 
simply a side effect due to its inactivation of tumor suppressor proteins.  However, 
these proteins can be inactivated under non-viral conditions, as seen in many cancers.  
Using the SV40 system to research this Tag-mediated inactivation mechanism may 
yield valuable insight.   
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 Initial research suggested that T antigen induced cell transformation by 
sequestering all the pools of tumor suppressor proteins
61
.  Further research has 
discovered that the J domain is necessary for cellular transformation.  More 
specifically, the interaction of the J domain with host cell proteins is the c rucial aspect 
of the transformation ability.  The presence of the J domain in T antigen, classifies it as 
a chaperone protein.  This chaperone functionality conferred by the J domain, suggests 
that a more dynamic mechanism for cellular transformation occurs.  
 Efficient cell transformation requires a functional J domain, the co-chaperone 
Hsc70, an intact LXCXE motif for pRb binding and a bound Cullin7.  It also requires a 
carboxy-terminal domain that is involved in the inactivation of the p53 protein.  Ther e 
are conflicting reports on whether the J domain is needed in the inactivation of p53.
61
   
All of these proteins are involved in regulating cell growth in some manner.   
 The binding of pRb is the first step in the T antigen mediated inactivation.  This 
research demonstrated that this interaction is strong as well as residue specific.  While 
bound to pRbA/B, J domain recruits and binds Hsc70.  The next step in the model is 
ATP hydrolysis and the separation of the Rb-E2F complex.  Further research must been 
carried out to determine how Rb and E2F are separated.  Under normal cellular 
conditions, the phosphorylation state of Rb changes yielding the release of E2F.  As a 
protein recruiting and binding machine, perhaps T antigen recruits a kinase to 
phosphorylate Rb.  Although it could simply be a conformational change that induces 
the release.  After E2F is released, the fate of the Rb protein needs to be explored.   
Cullin7 contains an LXCXE motif, so perhaps Rb becomes as substrate to Cullin7 
mediated poly-ubiquitination and degradation.   
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 If Cullin7 is truly part of this mechanism, the point at which it binds to T antigen 
should be investigated and added to the model.  It is known that the binding of Cullin7 
does not disrupt bound pRb but the relationship with Hsc70 is unknown.  Whether these 
proteins form stable or transient complex should be investigated.  My research provided 
a SAXS profile of T antigen bound to pRbA/B.   SAXS performed on a complex of the 
T antigen construct containing the J domain and LXCXE motif (N 117), pRbA/B and 
Cul7CPH domain could shed light on the organization of the proteins in this putative 
complex.   
 
Influence of pRb binding on T antigen dynamics 
 The studies presented in Chapter II explore the dynamics of the J domain of 
SV40 T antigen and the effect that binding of pRb protein has upon its motional 
freedom.  The J domain was found to be structurally and functionally independent of 
the other T antigen domains.  The NMR HSQC spectrum of the T antigen construct 
containing the J domain and OBD (N260) clearly demonstrated that these domains 
tumble independently in solution (Figure 2.2).  The SAXS derived P(r) functions 
showed interatomic distances corresponding to flexibly attached domains.  The NMR 
results revealed that upon binding of pRb, the OBD remained independent of the 
interaction and the J domain retained some motional freedom.  The SAXS data 
generated Dmax and Rg values reflecting no compaction of T antigen upon pRb 
binding.  These results support a model in which the J domain remains dynamic and 
therefore able to recruit additional proteins to a complex that inactivates tumor 
suppressor proteins.  This model is supported by studies showing the J domain of T 
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antigen recruits Hsc70
92,128
, and that binding to Cullin7 does not disrupt the interaction 
with pRb
124
.  The dynamic nature of the J domain and T antigen in general, permits the 
formation of multiple protein complexes that deregulate cellular processes yielding the 
production of a transformed cell.  
 
The dynamic J domain 
 SV40 mediated cell transformation 
requires the dynamic activity of the T antigen 
protein to disrupt normal cell functions.  
Disruption of these functions is made possible 
by the multiple domains of T antigen, in 
particular the J domain.  The J domain is 
flexibly attached to the remainder of the 
protein.  In the exploration of replication 
protein A, flexibly linked domains were 
deemed an important foundation for dynamic 
architecture as well as for the recruitment and 
binding of proteins and ultimately 
function
129,130
.  These same observations can be 
applied to the J domain of T antigen and 
provide insight on its ability to transform cells.   
 The questions posed at the beginning of 
this research were directed to the mode in 
A 
C 
B 
Figure 4.1.  Mode of T antigen and pRbA/B 
binding.  The structures of the T antigen J 
domain (green, 1GH6), connected with OBD 
(purple) bound to pRbA/B (cyan) in three 
conformations.    
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which pRb bound to T antigen.  Previous research demonstrated that a peptide 
containing the LXCXE motif is sufficient to bind the pRb protein
106
.  Could pRb bind in 
a manner that does not affect the domains of T antigen as represented in Figure 4.1A?  
The crystal structure of J domain and pRbA/B showed that two thirds of the interaction 
surface is through the LXCXE motif
68
.  NMR studies described in Chapter II confirm 
that there are J domain residues that are affected by pRb binding.  While pRb interacts 
with the J domain, does it bind to the OBD as well forming a compact complex as seen 
in Figure 4.1B?  The SAXS data ruled out this mode of binding.  The NMR evidence 
shown in Chapter II supports an interaction in which some J domain residues are 
involved but many remain unaffected.  These unchanged residues reflect retention of 
conformational freedom or flexibility in the structure.  Flexibility in a domain provides 
an opportunity for binding of additional proteins.  As the mechanism of T antigen 
mediated transformation is researched, the necessity for a dynamic J domain becomes 
more apparent.  An examination of how restricting the motion of the J domain affects 
protein binding could be performed by deleting and/or mutating the inter -helical 
unstructured regions or the linker between the J and OBD.  A static J domain may have 
difficulty recruiting proteins and thus transforming cells.   
 
Chaperones and Cancer 
 Research has shown that T antigen uses its chaperone ability to inactivate tumor 
suppressor proteins, transform cells and produce tumors.  It is not clear that SV40 T 
antigen does this in human cells.  However, some protein or protein complex is 
inactivating Rb and p53 proteins.  It is possible that some non-viral chaperone is 
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inactivating these proteins in a manner similar to T antigen.   One may believe that this 
human Rb inactivating protein would have been found, with all the technology and 
scientific advances that have occurred since the discovery of SV40.  However, there   
are new proteins discovered every day and the connection between chaperones and 
cancer is gaining renewed interest.  In fact, Hsc70 and Hsp75 has been shown to bind to 
pRb
131,132
.  The Hsc70 protein, the co-chaperone of T antigen, is mutated in some breast 
cancers
61
.  The Hsp70 protein, a chaperone that is expressed under cell stress 
conditions, along with its co-chaperone Hsp40, has also been shown to inhibit 
apoptosis
133,134
.  This same protein is the co-chaperone of Hsp90.  Hsp90 functions in 
multi-protein complexes through which it regulates the stability and activity of client 
proteins such as HER-2 and SRC, which are important in breast cancer progression.   
The overexpression of Hsp90 has been observed in a variety of cancers
135
.  Recently 
medical researchers have begun targeting heat shock proteins as sources of therapeutic 
intervention in a number of diseases
136
.   
 On the other hand, there are gaps in our knowledge of Tag mediated inactivation 
of pRb so there may not be a Tag-like chaperone.  In the current mechanism, it is not 
clear how Tag releases pRb from E2F.  It is known that in a normal environment, 
alteration of the pRb phosphorylation state releases the bound E2F.  It is also known 
that pRb is inactivated by CDK4/6 phosphorylation
137
.  Could Tag recruit a kinase to act 
upon pRb or mimic the change via induced structural conformation?  Revealing and 
properly placing the remaining pieces of the Tag chaperone mediated inactivation 
puzzle and comparing it with known data may yield a complete  answer as to how pRb is 
being inactivated. 
89 
 
Significance 
 The focus of the work presented in this dissertation highlights the influence of 
cellular proteins on the SV40 T antigen with specific focus on the J domain.   This 
research contributes observations on the dynamics of T antigen and its protein 
interactions.  These findings will contribute to fully identifying the mechanism of T 
antigen in protein recruitment and cellular transformations.  SV40 T antigen has been 
extensively researched.   However the independent nature of the domains, in particular 
the J domain and host range domain, suggests that there is still more insi ght to be 
gained by studying domain fragments and their binding partners.  This research 
demonstrated that protein structural dynamics is influenced, whether modestly or 
dramatically, by the proteins to which they interact.   Understanding the interactions on 
at higher resolutions will allow for understanding the function and activity of the multi -
protein machines.   
 The proteins that T antigen target are critical components in cellular growth and 
their deregulation results in diseases like cancer.  My research has expanded the 
knowledge of the dynamic nature of the J domain of T antigen and surveyed the effects 
of pRbA/B and Cul7CPH protein binding.  Elucidating the mechanism by which T 
antigen inactivates proteins like pRb, is critical for understanding how a non-viral 
protein could perform the same function.  The majority of cancers have a defect in the 
pRb protein, so determining the mode of pRb inactivation is fundamental to its 
treatment.  When that non-viral, pRb inactivating protein is discovered, this may open 
the door to the development of new anticancer therapeutics.   
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